Resumen congreso | 2024 |
A genome-wide association study for survival from a multi-center European study identified variants associated with the risk of death due to COVID-19
|
European Journal of Human Genetics |
Artículo | 2024 |
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
|
Scientific reports |
Artículo | 2024 |
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
|
HEPATOLOGY INTERNATIONAL |
Artículo | 2024 |
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|
ANNALS OF HEPATOLOGY |
Short Survey | 2024 |
Accuracy, Reliability, and Comprehensiveness of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2024 |
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2024 |
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy.
|
Nature Reviews Gastroenterology and Hepatology |
Revisión | 2024 |
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
|
JOURNAL OF HEPATOLOGY |
Revisión | 2024 |
Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance
|
RNA BIOLOGY |
Capítulo | 2024 |
Cirrosis hepática descompensada.
|
Medicina interna |
Artículo | 2024 |
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score
|
LIVER INTERNATIONAL |
Artículo | 2024 |
Evaluation of Google Search Trends for Liver Diseases in Europe
|
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES |
Artículo | 2024 |
FIB-4 score as predictor of COVID-19-related severity in hospitalized patients.
|
Revista Española de Enfermedades Digestivas |
Artículo | 2024 |
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
Artículo | 2024 |
Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
|
JOURNAL OF HEPATOLOGY |
Artículo | 2024 |
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom
|
PLOS ONE |
Revisión | 2024 |
Hepatic encephalopathy: experimental drugs in development and therapeutic potential
|
Expert Opinion on Investigational Drugs |
Artículo | 2024 |
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
|
SEMINARS IN LIVER DISEASE |
Letter | 2024 |
Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)
|
HEPATOLOGY |
Artículo | 2024 |
LiverAI: New tool in the landscape for liver health
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.
|
GUT |
Editorial | 2024 |
Looking for the best algorithm in the diabetes population for advanced fibrosis detection: the best is the enemy of the good
|
HEPATOLOGY |
Artículo | 2024 |
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information
|
PLOS ONE |
Editorial | 2024 |
Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
|
Endocrinología, diabetes y nutrición |
Revisión | 2024 |
Navigating the link between non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis and cardiometabolic syndrome
|
EUROPEAN CARDIOLOGY REVIEW |
Revisión | 2024 |
Novel approaches in the medical management of compensated cirrhosis
|
Expert Review of Gastroenterology and Hepatology |
Revisión | 2024 |
Novel insights into metabolic-associated steatotic liver disease preclinical models
|
LIVER INTERNATIONAL |
Artículo | 2024 |
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
Artículo | 2024 |
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis
|
HEPATOLOGY |
Artículo | 2024 |
Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
|
JOURNAL OF HEPATOLOGY |
Short Survey | 2024 |
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study.
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
|
HEPATOLOGY |
Artículo | 2024 |
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
|
GUT |
Artículo | 2024 |
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
|
HEPATOLOGY |
Artículo | 2024 |
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
|
HEPATOLOGY INTERNATIONAL |
Artículo | 2024 |
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
|
Journal of Gastroenterology |
Artículo | 2024 |
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
|
JHEP Reports |
Artículo | 2024 |
The Janus of a disease: diabetes and metabolic dysfunction-associated fatty liver disease
|
ANNALS OF HEPATOLOGY |
Artículo | 2024 |
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach.
|
EUROPEAN CARDIOLOGY REVIEW |
Artículo | 2024 |
Trombocitopenia grave asociada a enfermedad hepática crónica en España: resultados de un estudio retrospectivo utilizando aprendizaje automático y procesamiento de lenguaje natural
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
|
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
Artículo | 2023 |
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|
HEPATOLOGY |
Revisión | 2023 |
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
|
JOURNAL OF HEPATOLOGY |
Letter | 2023 |
A second update on mapping the human genetic architecture of COVID-19.
|
NATURE |
Artículo | 2023 |
AEEH «Consensus about detection and referral of hidden prevalent liver diseases»
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2023 |
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.
|
LIVER INTERNATIONAL |
Artículo | 2023 |
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
|
Hepatobiliary Surgery and Nutrition |
Artículo | 2023 |
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
|
HEPATOLOGY INTERNATIONAL |
Resumen congreso | 2023 |
Analysis of the diagnostic accuracy of the non-invasive fibrosis indices NFS, HFS, and FIB-4 in the staging of advanced fibrosis in patients with metabolic fatty liver: meta-analysis of comparative studies
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
At- risk nash identification using an algorithm that combines fib-4+masef ( metabolomicsadvanced steatohepatitis fibrosis score)
|
HEPATOLOGY |
Artículo | 2023 |
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study
|
LANCET GASTROENTEROLOGY & HEPATOLOGY |
Resumen congreso | 2023 |
Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Biomimetic superabsorbent hydrogel acts as a gut protective dynamic exoskeleton improving metabolic parameters and expanding A. muciniphila
|
Cell Reports Medicine |
Artículo | 2023 |
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
|
Biomarker Research |
Artículo | 2023 |
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
|
JHEP Reports |
Artículo | 2023 |
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
|
JOURNAL OF VIRAL HEPATITIS |
Revisión | 2023 |
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: From diagnosis to prognosis
|
ANNALS OF HEPATOLOGY |
Resumen congreso | 2023 |
Clinical utility of liver and spleen elastography in the management of patients living with liver disease
|
HEPATOLOGY |
Artículo | 2023 |
Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease.
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Resumen congreso | 2023 |
Clinically significant pruritus in patients with chronic liver disease (CLD): data from the global liver registry™ (GLR™)
|
GASTROENTEROLOGY |
Artículo | 2023 |
Co-08. Utilidad clínica de la elastografía hepática y esplénica en el manejo de pacientes que viven con enfermedad hepática
|
Revista Andaluza de Patología Digestiva |
Artículo | 2023 |
Co-10. La relevancia y realidad de la monitorización de la enfermedad mineral ósea en la colangitis biliar primaria
|
Revista Andaluza de Patología Digestiva |
Artículo | 2023 |
Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Corrección | 2023 |
Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022))
|
JOURNAL OF HEPATOLOGY |
Corrección | 2023 |
Corrigendum to “EASL clinical practice guidelines on the management of hepatic encephalopathy” [J Hepatol 2022 (77) 807–824](S0168827822003464)(10.1016/j.jhep.2022.06.001)
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Development and validation of a new imaging biomarker combining demili and mre to identify at risk nonalcoholic steatohepatitis ( at- risk nash) patients
|
HEPATOLOGY |
Artículo | 2023 |
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Development and validation of the AMMON-OHE model to risk stratify cirrhotic outpatients for ocurrence of overt hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Dr. José Aguilar Reina
|
Revista Andaluza de Patología Digestiva |
Editorial | 2023 |
Editorial: Feeling better about NASH-Authors' reply
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Resumen congreso | 2023 |
Efficacy and safety of efinopegdutide in hispanic patients with nonalcoholic fatty liver disease: results from an active comparator-controlled study
|
HEPATOLOGY |
Resumen congreso | 2023 |
Efficacy of efinopegdutide in nonalcoholic fatty liver disease: subgroup analyses from an active-comparator-controlled study
|
HEPATOLOGY |
Resumen congreso | 2023 |
Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Energy, exergy, economic and environmental analysis of a regasification system integrating simple ORC and LNG open power cycle in floating storage regasification units
|
BRODOGRADNJA |
Artículo | 2023 |
Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19
|
EUROPEAN JOURNAL OF EPIDEMIOLOGY |
Resumen congreso | 2023 |
Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2023 |
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
|
GUT |
Resumen congreso | 2023 |
Hepcityfree/ spanish alliance for viral hepatitis elimination: the commitment of spanish cities for hepatitis c elimination
|
HEPATOLOGY |
Resumen congreso | 2023 |
Identification of new serological biomarkers for the detection of significant fibrosis
|
HEPATOLOGY |
Artículo | 2023 |
Identification of Potential miRNA-mRNA Regulatory Axis of Intrahepatic cccDNA in Patients with Chronic Hepatitis B Virus Infection in the Grey Zone
|
HEPATITIS MONTHLY |
Artículo | 2023 |
Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with nonalcoholic fatty liver disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2023 |
Impact of Type 2 diabetes and obesity on quality of life in non-alcoholic fatty liver disease
|
INTERNATIONAL JOURNAL OF PSYCHOLOGY |
Artículo | 2023 |
Impacto de la enseñanza integrada de la patología médico-quirúrgica en pequeños grupos basada en la resolución de problemas en el aprendizaje de la medicina
|
Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla |
Artículo | 2023 |
Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: a randomised trial.
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2023 |
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) a randomised, double-blind, phase 3 trial
|
LANCET ONCOLOGY |
Artículo | 2023 |
Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma
|
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Artículo | 2023 |
Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
|
Contemporary Clinical Trials |
Artículo | 2023 |
Liver stiffness accuracy by MR elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort
|
Revista Española de Enfermedades Digestivas |
Artículo | 2023 |
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
|
GUT |
Resumen congreso | 2023 |
Longitudinal study of nafld progression using paired biopsies in a well-characterised european cohort
|
HEPATOLOGY |
Artículo | 2023 |
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: a development and validation study
|
HEPATOLOGY |
Artículo | 2023 |
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
|
FASEB JOURNAL |
Revisión | 2023 |
Metabolic dysfunction: The silenced connection with fatty liver disease
|
ANNALS OF HEPATOLOGY |
Artículo | 2023 |
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes
|
HUMAN MOLECULAR GENETICS |
Artículo | 2023 |
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
|
CELL DEATH & DISEASE |
Resumen congreso | 2023 |
Non-alcoholic fatty liver disease (nafld) is associated with significant impairment of work productivity: data from the global nash registry™
|
HEPATOLOGY |
Capítulo | 2023 |
Non-pharmacological treatment approach in patients with metabolic dysfunction-associated liver disease
|
Comprehensive Guide to Hepatitis Advances |
Artículo | 2023 |
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
|
BMJ-BRITISH MEDICAL JOURNAL |
Artículo | 2023 |
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease
|
JHEP Reports |
Artículo | 2023 |
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
|
Revista Española de Enfermedades Digestivas |
Artículo | 2023 |
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
|
LANCET GASTROENTEROLOGY & HEPATOLOGY |
Artículo | 2023 |
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2023 |
Potent and polyfunctional hepatitis b core (hbc)/surface (hbs)-specific cd8+and cd4+t cell responses observed in adults with chronic hepatitis b (chb) following targeted immunotherapy consisting of viral vectors in heterologous prime-boost regimen and adjuvanted hbc/hbs proteins: results on step b cohort of a phase i/ii trial
|
HEPATOLOGY |
Artículo | 2023 |
Predicting liver-related events in NAFLD: A predictive model
|
HEPATOLOGY |
Resumen congreso | 2023 |
Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease
|
DIGESTIVE AND LIVER DISEASE |
Artículo | 2023 |
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
|
JHEP Reports |
Revisión | 2023 |
Research priorities for precision medicine in NAFLD
|
CLINICS IN LIVER DISEASE |
Revisión | 2023 |
Review of green hydrogen technologies application in maritime transport
|
INTERNATIONAL JOURNAL OF GREEN ENERGY |
Artículo | 2023 |
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
|
LIVER INTERNATIONAL |
Artículo | 2023 |
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
|
HEPATOLOGY |
Resumen congreso | 2023 |
Serial vibration controlled transient elastography (vcte)-based agile scores predict liver-related events in nonalcoholic fatty liver disease (nafld) - a multicenter cohort study of 16,603 patients
|
HEPATOLOGY |
Artículo | 2023 |
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
|
GUT |
Resumen congreso | 2023 |
Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Stigma is a predictor of impairment of health related quality of life among patients with nafld
|
HEPATOLOGY |
Artículo | 2023 |
Tenofovir disoproxil fumarate reduces the severity of COVID-19 in patients with chronic hepatitis B
|
DIGESTIVE DISEASES AND SCIENCES |
Artículo | 2023 |
The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis
|
PLOS ONE |
Resumen congreso | 2023 |
The global survey of disease burden and stigma among patients with nafld and their healthcare providers
|
HEPATOLOGY |
Resumen congreso | 2023 |
Understanding barriers in non-alcoholic liver disease (nafld) management: insights from a multi-disciplinary survey of physicians in europe (barriers-nafld)
|
HEPATOLOGY |
Artículo | 2023 |
Update on the Role of Rifaximin in Digestive Diseases
|
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES |
Resumen congreso | 2023 |
What patients with nonalcoholic fatty liver disease should we treat with pharmacological agents?
|
HEPATOLOGY |
Artículo | 2022 |
A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2022 |
A cholestatic pattern predicts major liver-related outcomes in patients with nonalcoholic fatty liver disease.
|
LIVER INTERNATIONAL |
Artículo | 2022 |
A global survey of physicians knowledge about nonalcoholic fatty liver disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2022 |
A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy
|
CANCERS |
Artículo | 2022 |
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Revisión | 2022 |
Advancing the global public health agenda for NAFLD: a consensus statement
|
Nature Reviews Gastroenterology and Hepatology |
Resumen congreso | 2022 |
Approaches for a hepatitis C-free city: preliminary results
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival
|
Viruses |
Artículo | 2022 |
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
|
Biomarker Research |
Artículo | 2022 |
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
|
GUT |
Artículo | 2022 |
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
|
HEPATOLOGY |
Resumen congreso | 2022 |
Clinical and Patient-Reported Outcome (PRO) profile of patients with Hepatitis B Viral (HBV) infection from the Global Liver Registry (TM) (GLR (TM))
|
HEPATOLOGY |
Artículo | 2022 |
Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the global non-alcoholic steatohepatitis (NASH)/ non-alcoholic fatty liver disease (NAFLD) registry
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2022 |
Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual patient data meta-analysis
|
JOURNAL OF HEPATOLOGY |
Revisión | 2022 |
Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver
|
Frontiers in Endocrinology |
Corrección | 2022 |
Correction to: A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2022 |
Depression and emotional distress in patients with Chronic Liver Disease (CLD): data from the Global Liver Registry (TM) (GLR (TM))
|
HEPATOLOGY |
Artículo | 2022 |
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis
|
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
Artículo | 2022 |
Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2022 |
Diagnostic accuracy of MRE for staging hepatic fibrosis in patients with NAFLD
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
|
GUT |
Revisión | 2022 |
Dietary recommendations for the management of Non-alcoholic Fatty Liver Disease (NAFLD): a nutritional geometry perspective
|
SEMINARS IN LIVER DISEASE |
Resumen congreso | 2022 |
DIFFERENTIAL BIOMARKERS EXPRESSION IN THE TUMOR MICROENVIRONMENT OF RESECTED HEPATOCELLULAR CARCINOMA
|
HEPATOLOGY |
Resumen congreso | 2022 |
Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2022 |
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Revisión | 2022 |
Emerging pharmacological treatment options for MAFLD
|
Therapeutic Advances in Endocrinology and Metabolism |
Resumen congreso | 2022 |
EpCAM+CD133+Microvesicles: novel biomarker in NAFLD
|
HEPATOLOGY |
Revisión | 2022 |
Esteatohepatitis no alcohólica
|
MEDICINA CLINICA |
Artículo | 2022 |
Extracellular Vesicles as Biomarkers in Liver Disease
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Letter | 2022 |
Global multi-stakeholder endorsement of the MAFLD definition
|
LANCET GASTROENTEROLOGY & HEPATOLOGY |
Resumen congreso | 2022 |
Glutaminolysis and steatosis to steatohepatitis transition: role of glutaminase
|
HEPATOLOGY |
Artículo | 2022 |
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies.
|
Journal of Clinical and Translational Hepatology |
Artículo | 2022 |
Hepatic encephalopathy
|
Nature Reviews Disease Primers |
Artículo | 2022 |
Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception
|
FRONTIERS IN MOLECULAR BIOSCIENCES |
Resumen congreso | 2022 |
Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Resumen congreso | 2022 |
Impact of genes related to metabolic associated fatty liver disease (MAFLD) in response to hypocaloric dietary intervention: nutrigenomic analysis
|
HEPATOLOGY |
Resumen congreso | 2022 |
In cirrhotic patients with portal hypertension related bleeding. (B/PHT), the use of tamponade not followed by tips is an independent predictor of long-term (6-month and 1-year) mortality
|
HEPATOLOGY |
Artículo | 2022 |
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
|
JHEP Reports |
Artículo | 2022 |
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
|
Scientific reports |
Artículo | 2022 |
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2022 |
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma
|
LIVER INTERNATIONAL |
Artículo | 2022 |
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
|
HEPATOLOGY |
Artículo | 2022 |
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Novel genes and sex differences in COVID-19 severity.
|
HUMAN MOLECULAR GENETICS |
Artículo | 2022 |
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
|
LIVER INTERNATIONAL |
Artículo | 2022 |
Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study
|
NUTRICION HOSPITALARIA |
Resumen congreso | 2022 |
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
|
HEPATOLOGY |
Resumen congreso | 2022 |
Rescue tips (Rtips) must be considered as soon as a tamponade is used: results from two international multicenter cohorts of 3019 patients with portal hypertension (PTH)-related bleeding.
|
HEPATOLOGY |
Artículo | 2022 |
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: data from the global liver registry
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2022 |
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
|
Journal of Gastroenterology |
Artículo | 2022 |
The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Vitality, mental health and role-physical mediate the influence of coping on depressive symptoms and self-efficacy in patients with non-alcoholic fatty liver disease: a cross-sectional study
|
JOURNAL OF PSYCHOSOMATIC RESEARCH |
Resumen congreso | 2021 |
A global survey of physicians knowledge about non-alcoholic fatty liver disease (NAFLD)
|
GASTROENTEROLOGY |
Artículo | 2021 |
A machine learning approach enables quantitative measurement of liver histology and disease monitoring in NASH
|
HEPATOLOGY |
Artículo | 2021 |
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2021 |
A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis
|
NEW ENGLAND JOURNAL OF MEDICINE |
Artículo | 2021 |
A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH
|
NEW ENGLAND JOURNAL OF MEDICINE |
Artículo | 2021 |
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis
|
HEPATOLOGY |
Artículo | 2021 |
acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study
|
EClinicalMedicine |
Artículo | 2021 |
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.
|
JOURNAL OF CLINICAL INVESTIGATION |
Artículo | 2021 |
An experimental DUAL model of advanced liver damage
|
HEPATOLOGY COMMUNICATIONS |
Revisión | 2021 |
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
|
FRONTIERS IN IMMUNOLOGY |
Artículo | 2021 |
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
|
JHEP Reports |
Artículo | 2021 |
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2021 |
Circulating PCSK9 levels are correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease.
|
ATHEROSCLEROSIS |
Artículo | 2021 |
Circulating tumor cells enumeration from the portal vein for risk stratification in early pancreatic cancer patients
|
CANCERS |
Artículo | 2021 |
Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States
|
MEDICINE |
Artículo | 2021 |
Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old
|
CLINICAL PHARMACOLOGY & THERAPEUTICS |
Resumen congreso | 2021 |
CLINICAL PRESENTATION AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS: DATA FROM THE GLOBAL LIVER REGISTRY (TM)
|
GASTROENTEROLOGY |
Resumen congreso | 2021 |
Clinical presentation of lean non-alcoholic fatty liver disease (NAFLD) across the world: data from the global nash registry
|
GASTROENTEROLOGY |
Resumen congreso | 2021 |
CO-11. Monitorización de la adherencia a la dieta sin gluten mediante la determinación de péptidos inmunogénicos del gluten (gip) en orina: Concordancia con la lesión mucosa duodenal en los pacientes con enfermedad celiaca
|
Revista Andaluza de Patología Digestiva |
Artículo | 2021 |
CO-14. Evaluación de la capacidad diagnóstica de fibrosis y cuantificación de esteatosis hepática mediante rm en pacientes con esteatosis hepática metabólica (ehmet)
|
Revista Andaluza de Patología Digestiva |
Artículo | 2021 |
Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2021 |
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
|
EBIOMEDICINE |
Letter | 2021 |
COVID-19 and the liver: the chicken or the egg dilemma
|
Revista Española de Enfermedades Digestivas |
Revisión | 2021 |
Defining comprehensive models of care for NAFLD
|
Nature Reviews Gastroenterology and Hepatology |
Artículo | 2021 |
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
|
LIVER INTERNATIONAL |
Artículo | 2021 |
Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis.
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2021 |
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis
|
LIVER INTERNATIONAL |
Editorial | 2021 |
EASL international recognition award recipient 2021: Prof. Dr. Nahum Méndez-Sánchez
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data
|
GASTROENTEROLOGY |
Artículo | 2021 |
European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease?
|
JHEP Reports |
Artículo | 2021 |
Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis
|
Scientific reports |
Revisión | 2021 |
Gut-liver axis in nonalcoholic fatty liver disease: the impact of the metagenome, end products, and the epithelial and vascular barriers
|
SEMINARS IN LIVER DISEASE |
Resumen congreso | 2021 |
Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective.
|
World journal of virology |
Artículo | 2021 |
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis
|
Revista Española de Enfermedades Digestivas |
Artículo | 2021 |
Implementing personalized medicine in COVID-19 in Andalusia: an opportunity to transform the healthcare system.
|
Journal of personalized medicine |
Artículo | 2021 |
Influence of psychological biomarkers on therapeutic adherence by patients with non-alcoholic fatty liver disease: a moderated mediation model
|
JOURNAL OF CLINICAL MEDICINE |
Artículo | 2021 |
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review
|
Scientific reports |
Artículo | 2021 |
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2021 |
LOW HYPOCALORIC MEDITERRANEAN DIET VERSUS STANDARD DIET IN BIOPSY PROVEN NAFLD PATIENTS
|
HEPATOLOGY |
Artículo | 2021 |
Management of NAFLD patients with advanced fibrosis
|
LIVER INTERNATIONAL |
Artículo | 2021 |
Mapping the human genetic architecture of COVID-19.
|
NATURE |
Artículo | 2021 |
Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus
|
ADVANCED SCIENCE |
Artículo | 2021 |
Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2021 |
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2021 |
Overall clinical and economic impact of non-alcoholic fatty liver disease
|
Revista Española de Enfermedades Digestivas |
Artículo | 2021 |
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
|
JOURNAL OF HEPATOLOGY |
Editorial | 2021 |
Propuesta de nueva denominación: esteatosis hepática metabólica (EHmet)
|
Revista Española de Enfermedades Digestivas |
Artículo | 2021 |
Quality of life and coping in nonalcoholic fatty liver disease: influence of diabetes and obesity
|
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
Letter | 2021 |
Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD”
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Simple non-invasive scoring systems and histologic scores in predicting mortality in NAFLD patients: a systematic review and meta-analysis
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Letter | 2021 |
Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation
|
Clinical and translational medicine |
Artículo | 2021 |
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
|
EBIOMEDICINE |
Artículo | 2021 |
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2021 |
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility
|
PLOS ONE |
Revisión | 2021 |
Wilson's disease: revisiting an old friend
|
World Journal of Hepatology |
Artículo | 2020 |
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2020 |
A global review of national NAFLD and NASH policies
|
HEPATOLOGY |
Revisión | 2020 |
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2020 |
A retrospective registry review of chronic viral hepatitis patients and associated risk factors of late presentation to care in Spain, a country with unrestricted treatment access
|
HEPATOLOGY |
Resumen congreso | 2020 |
A systematic review of comprehensive models of care for NAFLD and NASH
|
HEPATOLOGY |
Artículo | 2020 |
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
|
LIVER INTERNATIONAL |
Resumen congreso | 2020 |
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis (NASH)
|
HEPATOLOGY |
Capítulo | 2020 |
Cirrosis hepática descompensada
|
Medicina interna [19ª ed.] |
Resumen congreso | 2020 |
Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH registry (TM)
|
HEPATOLOGY |
Artículo | 2020 |
Co-17. Determinación de micropartículas apoptóticas de origen hepático en pacientes con enfermedad hepática metabólica grasa
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2020 |
Coping strategies predicting quality of life in diabetic and obese NAFLD patients
|
EUROPEAN JOURNAL OF PUBLIC HEALTH |
Artículo | 2020 |
Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study
|
JHEP Reports |
Artículo | 2020 |
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
|
ANTIVIRAL RESEARCH |
Artículo | 2020 |
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2020 |
Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
|
MEDICINE |
Corrección | 2020 |
Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
Artículo | 2020 |
Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes
|
HEPATOLOGY COMMUNICATIONS |
Resumen congreso | 2020 |
FIB-4 and fibroscan can identify patients with nonalcoholic fatty liver disease who are at risk of liver-related events: results of a longitudinal analysis with comparison with liver biopsy
|
HEPATOLOGY |
Editorial | 2020 |
Foreword
|
NAFLD and NASH: biomarkers in detection, diagnosis and monitoring |
Artículo | 2020 |
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease
|
PLOS ONE |
Artículo | 2020 |
Genomewide association study of severe covid-19 with respiratory failure
|
NEW ENGLAND JOURNAL OF MEDICINE |
Artículo | 2020 |
Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study
|
Clinical and translational gastroenterology |
Resumen congreso | 2020 |
High prevalence of fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH): the impact on patient-reported outcomes (PROs)
|
DIABETES |
Revisión | 2020 |
Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice
|
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES |
Artículo | 2020 |
Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2020 |
Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease
|
DIGESTIVE AND LIVER DISEASE |
Artículo | 2020 |
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
|
GASTROENTEROLOGY |
Artículo | 2020 |
Management of chronic liver disease-associated severe thrombocytopenia in Spain: A view from the experts
|
Revista Española de Enfermedades Digestivas |
Capítulo | 2020 |
Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider?
|
Clinical Dilemmas in Viral Liver Disease, Second Edition |
Libro | 2020 |
NAFLD and NASH: Biomarkers in detection, diagnosis and monitoring
|
NAFLD and NASH: biomarkers in detection, diagnosis and monitoring |
Artículo | 2020 |
Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease
|
AMERICAN JOURNAL OF CLINICAL NUTRITION |
Artículo | 2020 |
Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice
|
Polish archives of internal medicine |
Resumen congreso | 2020 |
Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 regenerate study
|
DIGESTIVE AND LIVER DISEASE |
Resumen congreso | 2020 |
Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study
|
DIGESTIVE AND LIVER DISEASE |
Artículo | 2020 |
Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy
|
LIVER INTERNATIONAL |
Resumen congreso | 2020 |
Patient-reported outcomes in patients with chronic hepatitis C: data from the global liver registry (TM)
|
HEPATOLOGY |
Artículo | 2020 |
Programa poblacional de cribado de cáncer colorrectal. Documento de posicionamiento de la Sociedad Andaluza de Patología Digestiva. Requisitos mínimos para un cribado de calidad.
|
Revista Andaluza de Patología Digestiva |
Artículo | 2020 |
Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
|
FRONTIERS IN MEDICINE |
Artículo | 2020 |
qFIBS: an automated technique for quantitative evaluation of fibrosis, inflammation, ballooning, and steatosis in patients with nonalcoholic steatohepatitis
|
HEPATOLOGY |
Artículo | 2020 |
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
|
JOURNAL OF HEPATOLOGY |
Editorial | 2020 |
Redefining non-alcoholic fatty liver disease: what's in a name?
|
LANCET GASTROENTEROLOGY & HEPATOLOGY |
Resumen congreso | 2020 |
Selection based on SAF activity score, not NASH CRN NAFLD activity score, leads to selection of a patient cohort with more severe NASH with more advanced fibrosis: experience from the native phase 2b study of the panppar agonist lanifibranor
|
HEPATOLOGY |
Artículo | 2020 |
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials
|
JOURNAL OF HEPATOLOGY |
Artículo | 2020 |
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2020 |
Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians
|
HEPATOLOGY |
Artículo | 2020 |
Stratification of patients in NASH clinical trials: a pitfall for trial success
|
JHEP Reports |
Artículo | 2020 |
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
|
CELL METABOLISM |
Resumen congreso | 2020 |
The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries
|
DIGESTIVE AND LIVER DISEASE |
Resumen congreso | 2020 |
The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries
|
DIGESTIVE AND LIVER DISEASE |
Resumen congreso | 2020 |
The enhanced liver fibrosis (ELF) score predicts adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH)
|
DIABETES |
Resumen congreso | 2020 |
The European NAFLD policy index - how well are countries prepared?
|
HEPATOLOGY |
Artículo | 2020 |
The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease
|
Contemporary Clinical Trials |
Resumen congreso | 2020 |
The impact of chronic hepatitis B on patient-reported outcomes from the global liver registry (TM)
|
HEPATOLOGY |
Resumen congreso | 2020 |
The impact of fatigue on patient-reported outcomes (PRO) in patients with chronic liver disease (CLD): data from the global liver registry (GLR)
|
GASTROENTEROLOGY |
Resumen congreso | 2020 |
The panppar agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the native phase 2b trial
|
HEPATOLOGY |
Artículo | 2020 |
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
|
JOURNAL OF HEPATOLOGY |
Revisión | 2020 |
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management
|
LIVER INTERNATIONAL |
Resumen congreso | 2020 |
The serum-based metabolomics advanced steatohepatits fibrosis score (MASEF) for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant fibrosis
|
HEPATOLOGY |
Resumen congreso | 2020 |
Validation of a machine learning-based approach (delta liver fibrosis score) for the assessment of histologic response in patients with advanced fibrosis due to NASH
|
HEPATOLOGY |
Editorial | 2020 |
What has the COVID-19 pandemic taught us so far? Addressing the problem from a hepatologist’s perspective
|
Journal of Clinical and Translational Hepatology |
Artículo | 2019 |
A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy
|
OBESITY SURGERY |
Artículo | 2019 |
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3 ' UTR
|
JOURNAL OF HEPATOLOGY |
Artículo | 2019 |
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-beta 1 dependent mechanisms
|
Scientific reports |
Resumen congreso | 2019 |
ACUTE ON CHRONIC LIVER FAILURE IS A MAJOR RISK FACTOR FOR BLEEDING CONTROL AND MORTALITY, WHILE PRE-EMPTIVE TIPS IMPROVES SURVIVAL IN THESE PATIENTS
|
HEPATOLOGY |
Resumen congreso | 2019 |
Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials
|
DIGESTIVE AND LIVER DISEASE |
Resumen congreso | 2019 |
ALGORITHMS USING NONINVASIVE TESTS CAN ACCURATELY IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: DATA FROM THE STELLAR CLINICAL TRIALS
|
GUT |
Artículo | 2019 |
Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2019 |
Baseline characteristics of patients with and without diabetes in trials for advanced fibrosis/cirrhosis due to nonalcoholic steatohepatitis (NASH)
|
DIABETOLOGIA |
Artículo | 2019 |
Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization
|
FASEB JOURNAL |
Resumen congreso | 2019 |
CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY
|
HEPATOLOGY |
Resumen congreso | 2019 |
CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY
|
HEPATOLOGY |
Artículo | 2019 |
Co-03. La ldl oxidada es un biomarcador distintivo de la presencia de esteatohepatitis frente a fibrosis hepática en enfermedad hepática metabólica grasa
|
Revista Andaluza de Patología Digestiva |
Artículo | 2019 |
Co-12. Impacto de la fibrosis sobre la salud mental de pacientes con enfermedad hepática grasa no alcohólica (ehgna)
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2019 |
CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
|
HEPATOLOGY |
Resumen congreso | 2019 |
DESCRIPTION OF VIRAL HEPATITIS PATIENTS AND ASSOCIATED RISK FACTORS OF LATE PRESENTATION TO CARE IN SPAIN: A COUNTRY WITH UNRESTRICTED ACCESS TO TREATMENT
|
HEPATOLOGY |
Resumen congreso | 2019 |
DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT AND UNMET NEEDS OF PATIENTS WITH CHRONIC LIVER DISEASE-ASSOCIATED SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES IN SPAIN
|
VALUE IN HEALTH |
Resumen congreso | 2019 |
DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY.
|
HEPATOLOGY |
Artículo | 2019 |
Does the Antitumor Necrosis Factor-alpha Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?
|
JOURNAL OF CLINICAL DENSITOMETRY |
Resumen congreso | 2019 |
Droplet digital pcr analysis of circulating lncrna h19: a potential biomarker for hepatocellular carcinoma
|
HEPATOLOGY |
Artículo | 2019 |
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2019 |
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2019 |
Effects of fatty acids and polyphenols from extra virgin olive oil in a murine animal dietary model knockout for the LDL receptor
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study
|
JOURNAL OF HEPATOLOGY |
Artículo | 2019 |
Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2019 |
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
|
Revista Española de Enfermedades Digestivas |
Artículo | 2019 |
Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2019 |
Epigenetic regulation of gene expression in a HCC-NASH murine model
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
FACTORS PREDICTING SURVIVAL IN PATIENTS WITH 'NON-HIGH-RISK' ACUTE VARICEAL BLEEDING RECEIVING NSBB AND/OR EBL TO PREVENT RE-BLEEDING
|
HEPATOLOGY |
Resumen congreso | 2019 |
Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
Genetic Fingerprint of Hepatic Encephalopathy Risk in Liver Cirrhosis
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2019 |
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Editorial | 2019 |
Hepatic encephalopathy and traffic accidents: Vigilance is needed!
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
HETEROGENEITY OF CIRCULATING TUMOR CELLS BASED ON ASIALOGLYCOPROTEIN RECEPTOR 1 (ASGPR1) EXPRESSION IN HEPATOCELLULAR CARCINOMA AS PROGNOSTIC TOOL
|
HEPATOLOGY |
Artículo | 2019 |
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2019 |
IDENTIFICATION OF SERUM METABOLITES AS DIAGNOSTIC BIOMARKERS FOR ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
|
HEPATOLOGY |
Resumen congreso | 2019 |
Impact of age on routinely available non-invasive tests for the discrimination of advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
|
HEPATOLOGY |
Artículo | 2019 |
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
|
Revista Española de Enfermedades Digestivas |
Artículo | 2019 |
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2019 |
NONINVASIVE TESTS (NITS) MORE ACCURATELY CAPTURE SURROGATES OF CLINICAL RESPONSE THAN LIVER HISTOLOGY IN NASH PATIENTS WITH ADVANCED FIBROSIS
|
HEPATOLOGY |
Artículo | 2019 |
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
|
HEPATOLOGY |
Resumen congreso | 2019 |
OBESE PATIENTS CARRYING NAFLD-ASSOCIATED GENETIC VARIANTS PRESENT SPECIFIC SERUM AND LIVER LIPIDOMIC PROFILES: IDENTIFICATION OF A LIPIDOMIC SIGNATURE IN SERUM TO ESTIMATE THE LIVER FAT CONTENT
|
HEPATOLOGY |
Resumen congreso | 2019 |
OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH): A SECONDARY ANALYSIS OF THE PHASE 3 REGENERATE STUDY
|
HEPATOLOGY |
Artículo | 2019 |
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|
LANCET |
Resumen congreso | 2019 |
Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING
|
GASTROINTESTINAL ENDOSCOPY |
Resumen congreso | 2019 |
Overlap of primary biliary cholangitis and autoimmune hepatitis. Natural history and prognosis in a large cohort of patients from Spain
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLD
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
OXIDIZED-LDL AS A MARKER OF OXIDATIVE STRESS IS STRONGLY RELATED TO NASH IRRESPECTIVELY OF INSULIN RESISTANCE AND LIVER FIBROSIS
|
HEPATOLOGY |
Resumen congreso | 2019 |
PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIAL
|
HEPATOLOGY |
Artículo | 2019 |
Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study
|
HEPATOLOGY |
Otros | 2019 |
Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2019 |
RACE DOES NOT AFFECT THE PERFORMANCE OF ROUTINELY AVAILABLE NONINVASIVE TESTS FOR THE DISCRIMINATION OF ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE PHASE 3 STELLAR TRIALS OF SELONSERTIB
|
HEPATOLOGY |
Revisión | 2019 |
Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
|
TRANSPLANTATION |
Artículo | 2019 |
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2019 |
Relationship between self-perceived health, vitality, and posttraumatic growth in liver transplant recipients
|
FRONTIERS IN PSYCHOLOGY |
Artículo | 2019 |
Requisitos para la sedación en Unidades de Endoscopia Digestiva. Recomendaciones de la Sociedad Andaluza de Patología Digestiva.
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2019 |
Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
Rising economic burden following the diagnosis of compensated cirrhosis among hospitalized patients with Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in Spain
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
ROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIB
|
GUT |
Resumen congreso | 2019 |
SAFETY AND EFFICACY OF SELONSERTIB FOR THE TREATMENT OF BRIDGING FIBROSIS OR COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH): RESULTS OF THE PHASE 3 STELLAR STUDIES
|
HEPATOLOGY |
Resumen congreso | 2019 |
Sesión IV.: Búsqueda de biomarcadores en la enfermedad hepática metabólica grasa: aproximación transcriptómica
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2019 |
SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY
|
HEPATOLOGY |
Resumen congreso | 2019 |
THE BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE EU5 COUNTRIES
|
VALUE IN HEALTH |
Resumen congreso | 2019 |
The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
THE ECONOMIC COST AND HEALTH BURDEN OF NON ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIES
|
HEPATOLOGY |
Resumen congreso | 2019 |
The presence of type 2 diabetes is independently associated with impairment of patient- reported outcomes in patients with non-alcoholic steatohepatitis
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
The socio-economic burden of NASH in Europe and the United States: The gain study
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
Transcriptomic and epigenetic characterization of a NAFLD murine model
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2019 |
UREA CYCLE ENZYMES DYSREGULATION IS LINKED TO A MORE AGGRESSIVE NAFLD PHENOTYPE.
|
HEPATOLOGY |
Revisión | 2019 |
Use of Steatotic Grafts in Liver Transplantation: Current Status
|
LIVER TRANSPLANTATION |
Artículo | 2019 |
Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2019 |
VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
|
HEPATOLOGY |
Resumen congreso | 2019 |
VISCOELASTICITY AND STIFFNESS RESPONSE (VSR) WAS MODULATED BY ADIPOKINES HOMEOSTASIS BEYOND OF HCV CLEARANCE.
|
HEPATOLOGY |
Artículo | 2019 |
Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication
|
FOOD & FUNCTION |
Resumen congreso | 2019 |
What are the predictors of impairment of patient-reported outcome in non-alcoholic steatohepatitis?
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
A novel predictive model of liver decompensation in patients with non-alcoholic fatty liver related cirrhosis
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2018 |
Abide: A Novel Predictive Model of Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis.
|
HEPATOLOGY |
Resumen congreso | 2018 |
Advanced Fibrosis Based on Noninvasive Tests in Nonalcoholic Steatohepatitis (NASH) Is Associated with Impairment of Patient-Reported Outcomes
|
HEPATOLOGY |
Resumen congreso | 2018 |
Algorithms Using Noninvasive Tests Can Accurately Identify Patients with Advanced Fibrosis Due to Nash: Data from the Stellar Clinical Trials
|
HEPATOLOGY |
Resumen congreso | 2018 |
Burden and Variability in the Management of NAFLD Patients in Clinical Practice: Toward Unified Criteria.
|
HEPATOLOGY |
Resumen congreso | 2018 |
Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
Co-20. Mejora de la función endotelial en pacientes con virus c tras el tratamiento con aad
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2018 |
Co-21. Uso de microarns como biomarcadores no invasivos en enfermedad hepática metabólica por depósito de grasa no alcohólica
|
Revista Andaluza de Patología Digestiva |
Artículo | 2018 |
Co-28. Carga y variabilidad en el manejo de pacientes con ehgna en la práctica clínica: Hacia criterios unificados
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2018 |
Co-29. Investigación traslacional en ehgna: Estudio genético y funcional de fgf-21
|
Revista Andaluza de Patología Digestiva |
Artículo | 2018 |
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2018 |
Critical flicker frequency improves its diagnostic and predictive accuracy of hepatic encephalopathy by decreasing the dispersion between measures
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
Diabetes but Not Metabolic Syndrome Adversely Impact Survival or Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis.
|
HEPATOLOGY |
Artículo | 2018 |
Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis
|
LIVER INTERNATIONAL |
Resumen congreso | 2018 |
DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
|
Therapeutic Advances in Gastroenterology |
Resumen congreso | 2018 |
Dynamic of Microparticles in Patients with Hepatitis C Receiving Daa and Their Impact on Cardiovascular Risk: Hepcar Study
|
HEPATOLOGY |
Editorial | 2018 |
Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Resumen congreso | 2018 |
Effect of hepatitis C sustained virological response on the endothelial dysfunction and the cardiovascular risk. HepCAR study
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
EUS-GUIDED INTERVENTIONS ON THE VASCULAR SYSTEM: AN ACADEMIC SINGLE-CENTER EXPERIENCE
|
GASTROINTESTINAL ENDOSCOPY |
Resumen congreso | 2018 |
Extrahepatic Autoimmune Comorbidities in Patients with Primary Biliary Cholangitis. Lack of Association with Prognosis and Therapeutic Response to Ursodeoxycholic Acid.
|
HEPATOLOGY |
Corrección | 2018 |
Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349] Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2018 |
Fibroblast Growth Factor 21 (FGF21) in NAFLD: From a Biomarker to a Therapeutic Target.
|
HEPATOLOGY |
Artículo | 2018 |
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
|
GASTROENTEROLOGY |
Resumen congreso | 2018 |
Genetic and functional analysis of FGF21 in NAFLD/NASH
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
Genetic factors of hepatic encephalopathy on patients with cirrhosis: candidate gene study
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience
|
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
Artículo | 2018 |
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Otros | 2018 |
High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2018 |
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
Metabolically Healthy Obesity Is a Dynamic Condition Which Progress to Unhealthy Status According to Nash and Fibrosis Stage in Biopsy-Proven NAFLD Patients
|
HEPATOLOGY |
Resumen congreso | 2018 |
Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Metabolomic-Based Noninvasive Serum Test to Diagnose Nonalcoholic Steatohepatitis: Results From Discovery and Validation Cohorts
|
HEPATOLOGY COMMUNICATIONS |
Artículo | 2018 |
Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
|
Revista Española de Enfermedades Digestivas |
Artículo | 2018 |
Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Revisión | 2018 |
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2018 |
Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype
|
ANNALS OF HEPATOLOGY |
Resumen congreso | 2018 |
New Automated Evaluation Tool Qfibs - Quantitative Assessment for Fibrosis, Inflammation, Ballooning, and Steatosis in Patients with Non-Alcoholic Steatohepatitis
|
HEPATOLOGY |
Resumen congreso | 2018 |
Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality
|
HEPATOLOGY |
Resumen congreso | 2018 |
Non-alcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma listed for liver transplantation in United States: data from the Scientific Registry of Transplant Recipients
|
TRANSPLANTATION |
Revisión | 2018 |
Nuevas perspectivas terapéuticas en la esteatohepatitis no alcohólica
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2018 |
Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain
|
ANNALS OF HEPATOLOGY |
Resumen congreso | 2018 |
Pregnancy and autoimmune hepatitis: presentation and outcomes
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2018 |
Primary biliary cholangitis in Spain: fewer symptoms and milder disease at presentation, but similar therapeutic response over the years
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2018 |
Role of the Long Non-Coding RNA H19 in the Context of Hepatocellular Carcinoma
|
HEPATOLOGY |
Resumen congreso | 2018 |
Routinely Available Noninvasive Tests Discriminate Advanced Fibrosis Due to Nash in the Phase 3 Stellar Trials of the ASK1 Inhibitor Selonsertib
|
HEPATOLOGY |
Resumen congreso | 2018 |
Severe Impairment of Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis (NASH)
|
HEPATOLOGY |
Artículo | 2018 |
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
|
PLOS ONE |
Resumen congreso | 2018 |
Steatohepatitis and Fibrosis Influence the Occurrence of Type 2 Diabetes Mellitus during the Follow-up in Non-Diabetic Biopsy-Proven NAFLD Patients
|
HEPATOLOGY |
Artículo | 2018 |
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Revisión | 2018 |
The impact of minimal hepatic encephalopathy treatment in long-term prognosis
|
Salud(i)Ciencia |
Resumen congreso | 2017 |
A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasound
|
JOURNAL OF HEPATOLOGY |
Artículo | 2017 |
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naive and previously treated patients
|
Revista Española de Enfermedades Digestivas |
Artículo | 2017 |
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2017 |
An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice
|
MOLECULAR NUTRITION & FOOD RESEARCH |
Revisión | 2017 |
Cardiovascular assessment in liver transplant for nonalcoholic steatohepatitis patients: What we do, what we should do
|
World Journal of Hepatology |
Resumen congreso | 2017 |
Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry
|
JOURNAL OF HEPATOLOGY |
Artículo | 2017 |
Co-11. La frecuencia crítica de parpadeo mejora su rendimiento diagnóstico y predictivo de encefalopatía hepática al incorporar la desviación estándar como criterio de calidad
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-12. Papel del factor de crecimiento de fibroblasto 21 (fgf21) en pacientes con eghna: Estudio genético y funcional
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-19. Estudio del perfil epigenético en una cohorte de pacientes con hepatitis crónica c: Cirróticos versus hepatocarcinoma
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-20. Validación de los índices fib 4 y nfs para discriminar fibrosis hepática en pacientes con eghna en práctica clínica habitual.
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-26. Efectos secundarios e influencia sobre la rigidez hepática del metotrexate en pacientes con enfermedad de crohn
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-28. The impact of age on phenotypic presentation and severity in patients with idiosyncratic drug-induced liver injury (dili)
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2017 |
Comprehensive NAFLD diagnosis based on a noninvasive metabolomic approach in a liquid biopsy
|
JOURNAL OF HEPATOLOGY |
Editorial | 2017 |
Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offs
|
JOURNAL OF HEPATOLOGY |
Artículo | 2017 |
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
|
DIGESTIVE DISEASES AND SCIENCES |
Corrección | 2017 |
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
|
DIGESTIVE DISEASES AND SCIENCES |
Resumen congreso | 2017 |
Effectiveness And Safety Of Elbasvir/Grazoprevir Treatment For HCV Patients In Real-Life Clinical Practice: Results From Spanish Hepa-C Cohort
|
HEPATOLOGY |
Artículo | 2017 |
Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System
|
MEDICINA CLINICA |
Artículo | 2017 |
Endoscopic ultrasound-guided placement of plastic pigtail stents for the drainage of refractory malignant ascites
|
Endoscopy International Open |
Artículo | 2017 |
Evolution of the incidence of inflammatory bowel disease in Southern Spain
|
Revista Española de Enfermedades Digestivas |
Corrección | 2017 |
Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients (vol 111, pg 1456, 2016)
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2017 |
Genetic determinants influencing on overt hepatic encephalopathy and acute-on-chronic liver failure
|
JOURNAL OF HEPATOLOGY |
Editorial | 2017 |
Hepatitis B and NAFLD: Lives Crossed
|
ANNALS OF HEPATOLOGY |
Resumen congreso | 2017 |
HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis C
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2017 |
High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry
|
JOURNAL OF HEPATOLOGY |
Artículo | 2017 |
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
|
LIVER INTERNATIONAL |
Resumen congreso | 2017 |
Idiosyncratic Drug-Induced Liver Injury: A 20-Year Update of the Cases Enrolled by the Spanish dili Registry
|
DRUG SAFETY |
Artículo | 2017 |
IFN-lambda 3, not IFN-lambda 4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis
|
NATURE GENETICS |
Artículo | 2017 |
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2017 |
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy
|
LIVER INTERNATIONAL |
Artículo | 2017 |
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Resumen congreso | 2017 |
Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD
|
JOURNAL OF HEPATOLOGY |
Artículo | 2017 |
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
|
GASTROENTEROLOGY |
Resumen congreso | 2017 |
Modulation of the fecal metagenome in patients with Crohn's disease
|
JOURNAL OF CROHNS & COLITIS |
Resumen congreso | 2017 |
Oral glutamine challenge predicts risk and defines hepatic encephalopathy types
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2017 |
PROSPECTIVE DRUG-INDUCED LIVER INJURY REGISTRY: CLINICAL CHARACTERISTICS AND OUTCOMES OF 915 CASES
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Artículo | 2017 |
Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2017 |
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Resumen congreso | 2017 |
The impact of age on phenotype presentation and severity in patients with idiosyncratic drug-induced liver injury (DILI)
|
HEPATOLOGY |
Resumen congreso | 2017 |
The Long-Term Clinical Course of Histologically Advanced Nonalcoholic Fatty Liver Disease. Impact of Fibrosis Severity on Major Clinical Outcomes.
|
HEPATOLOGY |
Resumen congreso | 2017 |
Time in HE in cirrhotic patients with an acute episode (>= grade 2) determines short and long-term survival
|
JOURNAL OF HEPATOLOGY |
Letter | 2017 |
TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C
|
GASTROENTEROLOGY |
Artículo | 2017 |
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
|
HEPATOLOGY |
Revisión | 2017 |
Treatment of NAFLD with diet, physical activity and exercise
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2017 |
Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study.
|
HEPATOLOGY |
Resumen congreso | 2016 |
A NON-INVASIVE LIPIDOMIC TEST ACCURATELY DISCRIMINATES NON-ALCOHOLIC STEATOHEPATITIS FROM STEATOSIS: A BLIND VALIDATION STUDY
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2016 |
A POST-HOC ANALYSIS OF THE GOLDEN505 TRIAL DEMONSTRATES HISTOLOGICAL AND CARDIOMETABOLIC EFFICACY OF ELAFIBRANOR-120 MG IN PATIENTS WITH MODERATE OR SEVERE NASH THAT ARE ELIGIBLE FOR PHARMACOTHERAPY
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2 alpha/Ribavirin
|
PLOS ONE |
Resumen congreso | 2016 |
Advanced fibrosis is independently associated with impaired kidney function in biopsy-proven NAFLD. Results of a multicenter cross-sectional study
|
HEPATOLOGY |
Artículo | 2016 |
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study
|
JOURNAL OF CLINICAL GASTROENTEROLOGY |
Revisión | 2016 |
Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis
|
SEMINARS IN LIVER DISEASE |
Resumen congreso | 2016 |
Charlson Comorbidity Index predicts the overall benefit of IFN-free therapy in hepatitis (HepCom Study)
|
HEPATOLOGY |
Artículo | 2016 |
Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods
|
JOURNAL OF CLINICAL MICROBIOLOGY |
Resumen congreso | 2016 |
Critical Flicker Frequency predicts progression among stages of cirrhosis
|
HEPATOLOGY |
Artículo | 2016 |
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Development and Validation of a Noninvasive Prediction Model for Nonalcoholic Steatohepatitis Resolution After Lifestyle Intervention
|
HEPATOLOGY |
Resumen congreso | 2016 |
DEVELOPMENTAND VALIDATION OF A NON-INVASIVE MODEL FOR PREDICTING FIBROSIS RESOLUTION ONE YEAR AFTER LIFESTYLE INTERVENTION FOR BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITIS
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2016 |
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes
|
HEPATOLOGY |
Resumen congreso | 2016 |
Early-TIPS improves survival in high-risk variceal bleeders. Results of a Multicenter Variceal Bleeding Observational Study
|
HEPATOLOGY |
Artículo | 2016 |
Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets
|
Scientific reports |
Artículo | 2016 |
El ejercicio físico en la hepatitis crónica C: Revisión en la literatura
|
Revista Andaluza de Patología Digestiva |
Artículo | 2016 |
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|
GASTROENTEROLOGY |
Resumen congreso | 2016 |
Eliminating Hepatitis C in Spain: Bridging from the National Health Plan
|
HEPATOLOGY |
Artículo | 2016 |
Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2016 |
FibroGENE: A gene-based model for staging liver fibrosis
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2016 |
HCV GENOTYPE 3: META-ANALYSIS WITH AVAILABLE TREATMENT OPTIONS
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2016 |
HEPATOTOXICITY ASSOCIATED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. A COMPARATIVE ANALYSIS AMONG IBUPROFEN, DICLOFENAC AND NIMESULIDE FROM THE SPANISH AND LATIN-AMERICAN DILI REGISTRIES
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2016 |
HIGH RESOLUTION ANALYSIS FOR GENOTYPES AND SUB-GENOTYPES IDENTIFICATION IN HEPATITIS C REVEALS THE IMPORTANCE OF MIXED INFECTIONS FOR OPTIMAL THERAPY
|
JOURNAL OF HEPATOLOGY |
Letter | 2016 |
Identifying Patients With Nonalcoholic Steatohepatitis That Are Nonresponders to Therapy Reply
|
HEPATOLOGY |
Artículo | 2016 |
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
|
Scientific reports |
Resumen congreso | 2016 |
IMPACT OF BASAL COMORBIDITIES ON THE OVERALL BENEFIT OF DAA THERAPY IN HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2016 |
IMPACT OF GWAS-IDENTIFIED COMMON VARIANTS ON HISTOPATHOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis
|
DIGESTIVE AND LIVER DISEASE |
Resumen congreso | 2016 |
Improvement of carotid intima-media thickness and ankle-brachial index in patients with hepatitis C virus after IFN-free treatment.
|
HEPATOLOGY |
Artículo | 2016 |
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study
|
PSYCHOPHARMACOLOGY |
Artículo | 2016 |
Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients
|
FRONTIERS IN PHARMACOLOGY |
Resumen congreso | 2016 |
LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis
|
HEPATOLOGY |
Artículo | 2016 |
Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2016 |
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
|
NATURE COMMUNICATIONS |
Resumen congreso | 2016 |
More than 10 years of experience of use methotrexate in Crohn's disease at Macarena Hospital, Sevilla, Spain
|
JOURNAL OF CROHNS & COLITIS |
Resumen congreso | 2016 |
More than 10 years of experience of use methotrexate in Ulcerative colitis at Macarena Hospital, Sevilla, Spain
|
JOURNAL OF CROHNS & COLITIS |
Resumen congreso | 2016 |
Oral glutamine challenge predicts and identifies long-term ammonia-related overt hepatic encephalopathy
|
HEPATOLOGY |
Artículo | 2016 |
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Revisión | 2016 |
Pharmacogenetics of ribavirin-induced anemia in hepatitis C
|
PHARMACOGENOMICS |
Resumen congreso | 2016 |
PLPNA3 STATUS IN NASH IS ASSOCIATED WITH INCREASED HISTOLOGICAL SEVERITY AT BASELINE BUT NOT WITH RESPONSE TO THERAPY IN THE GOLDEN-505 ELAFIBRANOR TRIAL
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry
|
RHEUMATOLOGY INTERNATIONAL |
Resumen congreso | 2016 |
RELATIONSHIP BETWEEN BASELINE HEPATIC DISEASE SEVERITY AND THE CARDIOMETABOLIC AND ANTI-INFLAMMATORY EFFECTS OF ELAFIBRANOR IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Remission maintained by monotherapy after biological plus immunosuppressive combination for Crohn's disease in clinical practice
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Letter | 2016 |
Reply to contribution on the topic of hypovitaminosis D in chronic hepatitis C
|
ANNALS OF HEPATOLOGY |
Revisión | 2016 |
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
|
CLINICAL MICROBIOLOGY AND INFECTION |
Resumen congreso | 2016 |
SCCA-IgM helps to identify patients at risk of long-term hepatocelullar carcinoma
|
HEPATOLOGY |
Artículo | 2016 |
Sedación endoscópica en la cirrosis hepática
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2016 |
Sofosbuvir/Ledipasvir plus Ribavirin achieves high SVR12 in genotype-3 patients with compensated cirrhosis and similar to Sofosbuvir plus Daclatasvir. A multicentre real life cohort
|
HEPATOLOGY |
Resumen congreso | 2016 |
Spanish Drug-Induced Liver Injury Registry: An update of 20-years prospective collection of idiosyncratic hepatotoxicity cases.
|
HEPATOLOGY |
Resumen congreso | 2016 |
THE FTO RS1421085 T > C POLYMORPHISM IS ASSOCIATED WITH THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2016 |
TREATMENT OF HEPATITIS C VIRUS IN PATIENTS WITH ADVANCED CIRRHOSIS: ALWAYS JUSTIFIED? ANALYSIS OF THE HEPA-C REGISTRY
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
28. Impacto de la medición objetiva de comorbilidades en el beneficio de la terapia antiviral libre de interferón en hepatitis C
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2015 |
99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b-Infected Patients Treated With Label-Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2015 |
Abordaje diagnóstico de la diarrea crónica en adultos
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2015 |
An international, phase 2 randomized controlled trial of the dual PPAR alpha-delta agonist GFT505 in adult patients with NASH
|
HEPATOLOGY |
Revisión | 2015 |
Assessing cardiovascular risk in hepatitis C: An unmet need
|
World Journal of Hepatology |
Artículo | 2015 |
Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2015 |
Beneficial effects of the dual PPAR alpha-delta agonist, GFT505, on hepatic and cardiometabolic markers in adult NASH patients.
|
HEPATOLOGY |
Resumen congreso | 2015 |
Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry
|
HEPATOLOGY |
Resumen congreso | 2015 |
CONTINUUM OF CARE OF HEPATITIS C FROM DETECTION TO CURE: IMPACT OF PEER-TO-PEER SESSIONS IN PRIMARY CARE
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2015 |
CRITICAL FLICKER FREQUENCY PREDICTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2015 |
DEVELOPMENT AND VALIDATION OF A SIMPLE CLINICAL PREDICTION MODEL TO IDENTIFY PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS RESOLUTION AFTER 52 WEEKS OF LIFESTYLE MODIFICATION
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2015 |
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Editorial | 2015 |
Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field
|
World Journal of Hepatology |
Artículo | 2015 |
Evolución de la incidencia hospitalaria de la enfermedad inflamatoria intestinal en Andalucía
|
Revista Andaluza de Patología Digestiva |
Artículo | 2015 |
Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection
|
Genes & Immunity |
Resumen congreso | 2015 |
FIRST REAL CLINICAL PRACTICE DATA ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR WITH HCV-CHRONICALLY INFECTED PATIENTS IN SPAIN: THE HepatiC REGISTRY EXPERIENCE
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2015 |
HCV genotype 3: Meta-analysis with current options
|
HEPATOLOGY |
Revisión | 2015 |
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Hepatitis C Virus Current and Evolving Treatments for Genotypes 2 and 3
|
GASTROENTEROLOGY CLINICS OF NORTH AMERICA |
Artículo | 2015 |
Hepatology highlights
|
ANNALS OF HEPATOLOGY |
Artículo | 2015 |
High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain
|
ANNALS OF HEPATOLOGY |
Artículo | 2015 |
High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods
|
JOURNAL OF CLINICAL MICROBIOLOGY |
Artículo | 2015 |
Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients
|
ANNALS OF HEPATOLOGY |
Resumen congreso | 2015 |
Impact of comorbidities on the benefit of DAA therapy in Hepatitis C
|
HEPATOLOGY |
Resumen congreso | 2015 |
IMPACT OF PHYSICAL ACTIVITY ON OXIDATIVE STRESS IN PATIENTS WITH HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2015 |
INFLUENCE OF METABOLIC RISK FACTORS IN HEPATOTOXICITY (DILI) PHENOTYPE AND OUTCOME
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
|
NATURE COMMUNICATIONS |
Letter | 2015 |
Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis Reply
|
GASTROENTEROLOGY |
Resumen congreso | 2015 |
METABOLIC RISK FACTORS AFFECT CLINICAL PHENOTYPE AND OUTCOME OF HEPATOTOXICITY (DILI)
|
CLINICAL THERAPEUTICS |
Resumen congreso | 2015 |
METFORMIN REDUCES HYPERAMMONEMIA IN PORTACAVAL SHUNTED RATS INHIBITING GLUTAMINASE ACTIVITY
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated With Survival of Patients With Cirrhosis
|
GASTROENTEROLOGY |
Artículo | 2015 |
Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2015 |
Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2015 |
OLIVE OIL COMSUMPTION AMELIORATES NON-ALCOHOLIC STEATOHEPATITIS INDUCED BY HYPERCALORIC AND HYPERLIPIDIC WESTERN DIETS
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2015 |
PHARMACOGENOMIC STUDY TO PREDICT RIBAVIRIN AND PROTEASE-INHIBITOR-RELATED ANEMIA IN HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study
|
PLOS ONE |
Revisión | 2015 |
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
|
World Journal of Hepatology |
Artículo | 2015 |
Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study
|
Revista Española de Quimioterapia |
Resumen congreso | 2015 |
QUERCETIN MODIFIES LIPID DROPLET MORPHOLOGY AND IMPAIRS HEPATITIS C VIRAL LIFE-CYCLE STEPS FROM ASSEMBLY TO REPLICATION STEPS
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Resumen congreso | 2015 |
ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC STEATOHEPATITIS DEVELOPMENT
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment
|
JOURNAL OF CLINICAL VIROLOGY |
Artículo | 2015 |
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis
|
LIVER INTERNATIONAL |
Editorial | 2015 |
Sofosbuvir Modulates the Intimate Relationship Between Hepatitis C Virus and Lipids
|
HEPATOLOGY |
Resumen congreso | 2015 |
Substantial variability of the diagnostic accuracy of serum fibrosis markers across multiple cohorts of nash patients in various centers : the case for the negative predictive value
|
HEPATOLOGY |
Resumen congreso | 2015 |
The hepatic and extra-hepatic profile of resolution of steatohepatitis induced by GFT-505
|
HEPATOLOGY |
Capítulo | 2015 |
The oral glutamine challenge in liver cirrhosis
|
Glutamine in Clinical Nutrition |
Artículo | 2015 |
The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity
|
LIVER INTERNATIONAL |
Letter | 2015 |
Trombosis portal: más allá de la cirrosis hepática
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2015 |
TYPE 2 DIABETES REDUCES OVERALL SURVIVAL AND INCREASES THE RISK OF HEPATIC DECOMPENSATION IN HCV-RELATED LIVER CIRRHOSIS. RESULTS FROM A PROSPECTIVE LONG-TERM STUDY DURING 8 YEARS
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
|
JOURNAL OF VIRAL HEPATITIS |
Resumen congreso | 2015 |
WEIGHT LOSS INTENSITY IS STRONGLY ASSOCIATED TO IMPROVEMENT OF HISTOLOGICAL PARAMETERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AFTER 52 WEEKS OF LIFESTYLE MODIFICATION
|
JOURNAL OF HEPATOLOGY |
Artículo | 2015 |
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
|
GASTROENTEROLOGY |
Artículo | 2014 |
ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV
|
NEW ENGLAND JOURNAL OF MEDICINE |
Resumen congreso | 2014 |
Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study
|
HEPATOLOGY |
Resumen congreso | 2014 |
ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Bacterial antigen translocation in patients with cirrhosis and minimal hepatic encephalopathy is associated with increased serum ammonia and nitric oxide levels
|
HEPATOLOGY |
Resumen congreso | 2014 |
CHRONICITY IN IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): CAUSATIVE DRUGS AND RISK FACTSORS
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Resumen congreso | 2014 |
Comparisons of Populations in Faldaprevir Phase III Studies Based on Pegylated Interferon alpha-2A and Ribavirin-Predicted Responsiveness and Impact on Achieving Svr12
|
GASTROENTEROLOGY |
Resumen congreso | 2014 |
COMPARISONS OF POPULATIONS IN FALDAPREVIR PHASE III STUDIES BASED ON PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN-PREDICTED RESPONSIVENESS AND IMPACT ON ACHIEVING SVR12
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
COST-EFFECTIVENESS ANALYSIS OF ELTROMBOPAG AS SUPPORT TREATMENT IN CHRONIC HCV INFECTED PATIENTS WITH THROMBOCYTOPENIA TO ENABLE INTERFERON-BASED REGIMENS
|
VALUE IN HEALTH |
Resumen congreso | 2014 |
COST-EFFECTIVENESS ANALYSIS OF TRIPLE THERAPY WITH PEGINTERFERON, RIBAVIRIN, AND BOCEPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 WITH SEVERE FIBROSIS UNDER "REAL-LIFE" CONDITIONS
|
VALUE IN HEALTH |
Editorial | 2014 |
Deciphering the Spectrum of Low-Grade Hepatic Encephalopathy in Clinical Practice
|
GASTROENTEROLOGY |
Resumen congreso | 2014 |
DETECTION AND DERIVATION RATE AFTER PEER-TO-PEER TRAINING SESSIONS IN PRIMARY CARE ON THE SCREENING OF HEPATITIS B
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Early Stopping Rules for Faldaprevir Plus Pegylated Interferon alpha-2A and Ribavirin in Treatment-Naive Patients: Exploratory Study of Pooled Data From Phase III Trials
|
GASTROENTEROLOGY |
Resumen congreso | 2014 |
EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Efficacy by Race or Geographic Region in HCV Genotype 1-infected Patients Treated with ABT-450/ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin
|
HEPATOLOGY |
Artículo | 2014 |
Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection
|
GASTROENTEROLOGY |
Resumen congreso | 2014 |
Entecavir has high efficacy and safety in Caucasian patients with chronic hepatitis B and co-morbidities
|
JOURNAL OF VIRAL HEPATITIS |
Resumen congreso | 2014 |
FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIES
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naive Patients: Pooled Analysis of Phase III Studies
|
GASTROENTEROLOGY |
Resumen congreso | 2014 |
FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV)
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
GLUTAMINASE GENE ALTERATION DETERMINES THE ABILITY TO PREDICT OVERT HEPATIC ENCEPHALOPATHY BOUTS BY CRITICAL FLICKER FREQUENCY AND ORAL GLUTAMINE CHALLENGE
|
JOURNAL OF HEPATOLOGY |
Revisión | 2014 |
HCV genotype 3 - the new treatment challenge
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2014 |
Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2014 |
Hepatotoxicidad inducida por estanozolol
|
Revista Andaluza de Patología Digestiva |
Artículo | 2014 |
Hepatotoxicity associated with statin use: Analysis of the cases included in the Spanish Hepatotoxicity Registry
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2014 |
HERBALS AND DIETARY SUPPLEMENT (HDS) PRODUCTS: A GROWING CAUSE OF HEPATOTOXICITY IN THE SPANISH DILI REGISTRY
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Letter | 2014 |
Hypoxic hepatitis as diabetic ketoacidosis complication
|
Revista Española de Enfermedades Digestivas |
Artículo | 2014 |
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection
|
JOURNAL OF HEPATOLOGY |
Artículo | 2014 |
Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease
|
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION |
Revisión | 2014 |
Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Resumen congreso | 2014 |
Killer Ig-like receptors (KIR) profiles and HLA class I ligands in amoxicillin-clavulanate-induced hepatotoxicity
|
HEPATOLOGY |
Artículo | 2014 |
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
|
NEW ENGLAND JOURNAL OF MEDICINE |
Resumen congreso | 2014 |
LOSS OF GATA4 IN HEPATIC STELLATE CELLS PROMOTES LIVER FIBROSIS
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Low Incidence of Hyperbilirubinemia Events With ABT-450/r-Ombitasvir and Dasabuvir With or Without Ribavirin in HCV Genotype-1 Infected Patients
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2014 |
META-ANALYSIS: ROLE OF INSULIN SENSITIZERS ADDED TO PEGINTERFERON AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Metformin reduces hyperammonemia in portacaval shunted rats inhibiting intestinal glutaminase activity
|
HEPATOLOGY |
Resumen congreso | 2014 |
NON-INVASIVE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
|
JOURNAL OF HEPATOLOGY |
Artículo | 2014 |
Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats
|
JOURNAL OF HEPATOLOGY |
Artículo | 2014 |
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C
|
ANNALS OF HEPATOLOGY |
Artículo | 2014 |
Polycystic liver in the adult (PLA) in Spain: Analysis of a structured survey analysing the experience and attitude of Spanish gastroenterologists
|
Revista Española de Enfermedades Digestivas |
Artículo | 2014 |
Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2014 |
PROGNOSTIC MODEL FOR PREDICTING DRUG-INDUCED ACUTE LIVER FAILURE
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Protease inhibitors impair renal function in HCV-infected immunocompetent patients
|
HEPATOLOGY |
Resumen congreso | 2014 |
Quercetin inhibits both replication and assembly of hepatitis C virus by blocking the viral NS3 and the host diacylglycerol acyltransferase type 1
|
HEPATOLOGY |
Resumen congreso | 2014 |
QUERCETIN MODULATES LIPIDS DROPLETS IN Huh7 CELLS BEARING PNPLA3 GENOTYPE GG
|
JOURNAL OF HEPATOLOGY |
Artículo | 2014 |
Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2014 |
Regulation of the akt/mtor pathway by metformin in hepatocellular carcinoma development upon hcv infection
|
JOURNAL OF HEPATOLOGY |
Letter | 2014 |
Reply to: "Renal impairment and anemia during triple therapy"
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2014 |
Risk factors for chronicity in idiosyncratic drug-induced liver injury (DILI)
|
HEPATOLOGY |
Artículo | 2014 |
Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol
|
LIFE SCIENCES |
Artículo | 2014 |
Síndrome LPAC secundario a deleción del exón 4 del gen ABCB4 en un paciente con hepatitis C
|
Revista Española de Enfermedades Digestivas |
Artículo | 2014 |
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
|
NEW ENGLAND JOURNAL OF MEDICINE |
Editorial | 2014 |
Stanozolol-induced bland cholestasis
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2014 |
Statins and metformin use improve prognosis after diagnosis of hepatocelullar carcinoma
|
HEPATOLOGY |
Resumen congreso | 2014 |
Statins interfere on TCTP and PI3K/AKT/mTOR pathway and inhibit hepatocellular carcinoma progression
|
HEPATOLOGY |
Resumen congreso | 2014 |
SVR12 of 99% achieved with a ribavirin-free regimen ABT-450/R/ombitasvir and dasabuvir in HCV genotype 1b-infected patients
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2014 |
SVR12 of 99% Achieved With a Ribavirin-Free Regimen of ABT-450/r/Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2014 |
TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE
|
JOURNAL OF HEPATOLOGY |
Artículo | 2014 |
Terapia triple en pacientes con fibrosis avanzada y cirróticos aspectos relevantes en la práctica clínica
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 2014 |
Tetany and convulsions: Onset symptoms in crohn’s disease
|
Revista Española de Enfermedades Digestivas |
Artículo | 2014 |
THDP17 Decreases Ammonia Production through Glutaminase Inhibition. A New Drug for Hepatic Encephalopathy Therapy
|
PLOS ONE |
Resumen congreso | 2014 |
THE ROLE OF KILLER IG-LIKE RECEPTORS (KIR) AND HLA CLASS I PROFILES IN IDIOSYNCRATIC HEPATOTOXICITY
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Artículo | 2014 |
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
|
GASTROENTEROLOGY |
Resumen congreso | 2013 |
A candidate-gene approach to validation of genetic modifier associations using a large cohort with histologically characterised non-alcoholic fatty liver disease
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Algoritmo pronóstico para predecir fallo hepático fulminante en hepatotoxicidad
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Análisis de los factores que afectan a la utilidad de la elastografía transitoria en pacientes con cirrosis hepática
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Association between vitamin D and hepatitis C virus infection: A meta-analysis
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Editorial | 2013 |
Cirrhosis is less cirrhosis without virus C
|
ANNALS OF HEPATOLOGY |
Revisión | 2013 |
Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
Cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients
|
HEPATOLOGY |
Ponencia | 2013 |
Determination of fibrosis stage and steatohepatitis in patients with nafld by optical analysis of magnetic resonance images combined with artificial neural networks (Fibromri and nashmri)
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
Early virological response rates in monoinfected patients with HCV and coinfected with HCV/HIV, genotypes 1&4 treated with peginterferon alpha 2a and ribavirin. Optim study
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2013 |
Efficacy and safety of triple therapy with Peginterferon, Ribavirin, and Boceprevir within Early Access Program in Spanish patients with hepatitis c genotype 1 with severe fibrosis. SVRw12 Analisys
|
HEPATOLOGY |
Resumen congreso | 2013 |
Efficacy and safety of triple-therapy with peginterferon-ribavirin, and boceprevir as compassionate-use in Spanish patients with hepatitis C genotype 1 with severe fibrosis: Interim-analysis at 12 weeks
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2013 |
EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos)
|
GASTROINTESTINAL ENDOSCOPY |
Resumen congreso | 2013 |
Functional analysis of the diacylglycerol acyltransferase activity-1 (DGAT1) in the replication of hepatitis C virus: Effect of quercetin
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
Genetic variants of the Niemann-Pick C1-like 1 cholesterol absorption receptor and response to antiviral therapy in HCV patients
|
HEPATOLOGY |
Revisión | 2013 |
Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2013 |
Hepatotoxicidad por el uso ilícito de esteroides anabolizantes: Una serie prospectiva del registro español y latinoamericano
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2013 |
Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patients
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
|
PLOS ONE |
Resumen congreso | 2013 |
I148M PNPLA3 variant promotes steatosis according to viral and IL28B genotype but does not affect sustained viral response in patients with hepatitis C
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
IL28B-based model for prediction of week 4 viral response in peginterferon-alfa2a+ribavirin treated hepatitis C genotype 1&4. Final report week 4 optim study
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
Illicit use of anabolic androgenic steroids (AAS) for body building and idiosyncratic liver injury (DILI): A prospective series from the Spanish and Latin-American DILI registry
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Artículo | 2013 |
Impacto de la realización de sesiones formativas en la detección de la hepatitis b y c en atención primaria (ver tabla)
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Implementación clínica de demili®: Una nueva herramienta para la detección de esteatohepatitis y fibrosis avanzada en pacientes con enfermedad hepática por depósito de grasa no alcohólica (EGHNA)
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2013 |
Increased circulating soluble CD36 is associated with advanced steatosis in patients with nonalcoholic fatty liver disease
|
HEPATOLOGY |
Resumen congreso | 2013 |
Influence of PNPLA3 genotypes on histological features and adiponutrin serum levels in patients with NAFLD
|
HEPATOLOGY |
Artículo | 2013 |
Influencia de los genotipos de pnpla3 y niveles de adiponutrina sérica en las características histológicas en pacientes con enfermedad hepática por depósito de grasa no alcohólica (EGHNA)
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Editorial | 2013 |
Insulin Resistance, Telaprevir, and Virological Response in Hepatitis C: The Debate Must Go On
|
HEPATOLOGY |
Artículo | 2013 |
Introduction
|
Enfermedades infecciosas y microbiología clínica |
Ponencia | 2013 |
KLF12 polymorphism improves ITPA predictability of anemia in hepatitis C treated with peginterferon plus ribavirin
|
HEPATOLOGY |
Resumen congreso | 2013 |
KLF12 polymorphism rs9543524 predicts anemia in patients with chronic hepatitis C treated with peginterferon and ribavirin
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
La quercetina inhibe la replicación del virus de la hepatitis c (vhc), modifica el metabolismo lipídico, la morfología de los lipid droplets (lds) y la localización de core.
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Las variantes de pnpla3 promueven la esteatosis en función del genotipo viral y la ilb28 sin afectar a la respuesta viral sostenida en pacientes con hepatitis C
|
Revista Andaluza de Patología Digestiva |
Revisión | 2013 |
Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Ponencia | 2013 |
Metformin reduces plasmatic ammonia in portacaval shunted rats
|
HEPATOLOGY |
Artículo | 2013 |
Metformina reduce los niveles de amonio plástico en ratas con derivación portocava
|
Revista Andaluza de Patología Digestiva |
Letter | 2013 |
Mielotoxicidad por la interacción entre azatioprina y alopurinol en paciente con enfermedad de Crohn
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2013 |
Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular risk
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Papel de la regulación de la expresión génica y epigenética (micrornas) relacionada con el desarrollo de hepatocarcinoma en un modelo in vitro de infección por el virus de la hepatitis c. Efecto de la metformina
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2013 |
Phase II HCVac study of TG4040 immunotherapeutic in combination with PEGIFN alpha 2a and ribavirin in genotype 1 CHC treatment naive patients: SVR24 final results
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables
|
ANNALS OF HEPATOLOGY |
Artículo | 2013 |
PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naive HCV genotype 1/4 patients
|
HEPATOLOGY |
Resumen congreso | 2013 |
Quercetin inhibits HCV replication by modulating lipid droplets morphology and core protein co-localization
|
HEPATOLOGY |
Artículo | 2013 |
Role of diabetes mellitus on hepatic encephalopathy
|
METABOLIC BRAIN DISEASE |
Resumen congreso | 2013 |
Role of gene and microRNAs expression related to hepatocellular carcinoma development in a hcv-induced model in vitro. Effect of metformin
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
Role of protein tyrosine-phosphatase 1B (PTP1B) activity in HCV-induced hepatocellular carcinoma: An in vitro analysis
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2013 |
Serum levels of PNPLA3 are related to the development of steatohepatitis in non alcoholic fatty liver disease patients
|
HEPATOLOGY |
Resumen congreso | 2013 |
The HOMA index is a useful tool for risk stratification of advanced fibrotic disease in a large cohort of european NAFLD patients
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2013 |
Usefulness in clinical practice of NASHMRi for the detection of steatohepatitis in patients with NAFLD
|
HEPATOLOGY |
Resumen congreso | 2013 |
Validation study of the impact of SNPs from GWAS associated with fibrosis progression in chronic hepatitis C (HCV)
|
HEPATOLOGY |
Artículo | 2012 |
5. Recidiva tras el cambio de la doble terapia a la monoterapia en la enfermedad de Crohn
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2012 |
A GENOME-WIDE ASSOCIATION STUDY IDENTIFIED A NOVEL SUSCEPTIBILITY LOCUS GENE PBK (RS 17388536)FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS BEARING IL28B GENOTYPE CC
|
JOURNAL OF HEPATOLOGY |
Artículo | 2012 |
Análisis de la influencia del polimorfismo 1331T>C ABCB11 en la interacción funcional de los sitios activos de la proteína transportadora bsep y la toxicidad hepática inducida por fármacos (DILI)
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2012 |
Anti-LDL-oxidized antibodies: a link between NASH and cardiovascular disease
|
HEPATOLOGY |
Artículo | 2012 |
Determinación de la presencia de esteatohepatitis en enfermedad hepática por depósito de grasa no alcohólica (EHGNA) basado en el análisis óptico de resonancias magnéticas de hígado y redes neurales artificiales (FibroMRi)
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2012 |
Determination of the presence of Steatohepatitis in Non-Alcoholic Fatty Liver disease based on optical analysis of Liver MRI and artificial neural networks (FibroMRi)
|
HEPATOLOGY |
Ponencia | 2012 |
Early virological dynamics on genotype 1 & 4 coinfected (HCV/HIV) and monoinfected (HCV) patients treated with peginterferon-alpha 2a plus ribavirin. An interim analysis of the OPTIM study
|
HEPATOLOGY |
Ponencia | 2012 |
EFFECT OF ABCC2 HAPLOTYPES ON INDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) SUSCEPTIBILITY
|
JOURNAL OF HEPATOLOGY |
Artículo | 2012 |
Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Ponencia | 2012 |
Endoscopic Ultrasound (EUS) -Guided Therapy of Gastric Varices. Results From a Prospective Multicenter Study
|
GASTROINTESTINAL ENDOSCOPY |
Artículo | 2012 |
Entry of hepatitis C virus into the cell: A therapeutic target
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Ponencia | 2012 |
FACTORS INVOLVED IN SUSTAINED VIRAL RESPONSE (SVR) ACHIEVEMENT IN PATIENTS WITH FAVORABLE IL28B CC GENOTYPE IN HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD
|
HEPATOLOGY |
Artículo | 2012 |
HAVCR1 Gene Haplotypes and Infection by Different Viral Hepatitis C Virus Genotypes
|
CLINICAL AND VACCINE IMMUNOLOGY |
Ponencia | 2012 |
HEPATITIS C VIRUS MODIFIES PROTEIN AND GENE EXPRESSION OF THE INSULIN SIGNALING PATHWAY IN VIVO AND IN VITRO
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
HEPATITIS C VIRUS MODIFIES THE EXPRESSION OF MICRO-RNAS ASSOCIATED WITH APOPTOSIS AND METABOLIC SYNDROME IN HUH7.5 CELLS
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
HEPATITIS C VIRUS MODULATES LDL RECEPTOR (LDLR) GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS ACCORDING TO VIRAL CLEARANCE
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
HIGH VS STANDARD DOSE OF RIBAVIRIN PLUS PEGINTERFERON-ALFA-2A IN CHRONIC HEPATITIS C, GENOTYPE 3 AND HIGH VIRAL LOAD. FINAL RESULTS OF THE DARGEN-3 STUDY
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
HLA class I and II alleles influence the amoxicillin-clavulanate hepatotoxicity signature
|
HEPATOLOGY |
Artículo | 2012 |
Hyperammonemia induced oxidative stress in cirrhotic rats without promoting differential protein expression in the brain cortex: A 2D-DIGE analysis.
|
Advances in Bioscience and Biotechnology |
Ponencia | 2012 |
IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study
|
HEPATOLOGY |
Ponencia | 2012 |
Influence of IL-28B genotype on efficacy of retreatment with pegifn alfa-2A and ribavirin in patients with chc and failure of previous treatment (agora study): results at week 12
|
HEPATOLOGY |
Artículo | 2012 |
Influencia de la enfermedad hepática por hígado graso no alcohólico sobre la enfermedad cardiovascular: Metaanálisis
|
Revista Andaluza de Patología Digestiva |
Artículo | 2012 |
Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2012 |
Insulin Resistance Impairs Viral Dynamics Independently of Ethnicity or Genotypes
|
JOURNAL OF CLINICAL GASTROENTEROLOGY |
Artículo | 2012 |
Interacción entre los genotipos virales y del hospedador influenciados por la infección del virus de la hepatitis C
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2012 |
Interaction between host and viral genotypes influenced hepatitis C infection
|
HEPATOLOGY |
Ponencia | 2012 |
INTERACTION BETWEEN RS12979860 POLYMORHISM OF IL28B GENE WITH BASELINE PREDICTIVE FACTORS OF RESPONSE TO TREATMENT IN PATIENTS WITH HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2012 |
Invasive pulmonary aspergillosis in a young man with Crohn's disease.
|
Tropical gastroenterology : official journal of the Digestive Diseases Foundation |
Artículo | 2012 |
La modulación in vitro de la vía de señalización de la insulina afecta a la replicación del virus de la hepatitis C
|
Revista Andaluza de Patología Digestiva |
Artículo | 2012 |
Manejo actual de la Encefalopatía Hepática
|
Revista Andaluza de Patología Digestiva |
Artículo | 2012 |
Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
|
PLOS ONE |
Ponencia | 2012 |
METFORMIN PREVENTS OVERT HEPATIC ENCEPHALOPATHY (HE) IN CIRRHOTICS: A RETROSPECTIVE OBSERVATIONAL STUDY
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
METFORMIN TREATMENT REDUCES HEPATOCELLULAR CARCINOMA (HCC) RISK IN PATIENTS WITH CIRRHOSIS C: A RETROSPECTIVE OBSERVATIONAL STUDY OF TWO INDEPENDENT COHORTS
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2012 |
miRNAs involved in insulin resistance are regulated in vitro by HCV infection
|
HEPATOLOGY |
Ponencia | 2012 |
Non-alcoholic fatty liver disease (NAFLD) influences on cardiovascular disease: Meta-analysis
|
HEPATOLOGY |
Artículo | 2012 |
Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
|
JOURNAL OF PROTEOME RESEARCH |
Ponencia | 2012 |
Optical analysis of liver magnetic resonance images based on neural networks for the determination of fibrosis stage and distribution in non-alcoholic fatty liver disease (NAFLD)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2012 |
Pancreatitis aguda e infección por Salmonella Enteritidis
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2012 |
PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2012 |
Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Ponencia | 2012 |
PNPLA3 and DISC1 are associated with steatosis in patients with chronic hepatitis C
|
HEPATOLOGY |
Resumen congreso | 2012 |
Predictive Factors of Erythema Nodosum and Pyoderma Gangrenosum in a Spanish Cohort of 397 Patients With Inflammatory Bowel Disease
|
GASTROENTEROLOGY |
Letter | 2012 |
Relationship between H. pylori and hepatitis A virus infection
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2012 |
Retreatment of patients with Hepatitis C and failure of previous treatment with peg-ifn and RBV (agora study): results at week 12
|
HEPATOLOGY |
Artículo | 2012 |
The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance
|
PLOS ONE |
Revisión | 2012 |
Un nuevo escenario terapéutico en el tratamiento de la hepatitis crónica por virus C
|
FARMACIA HOSPITALARIA |
Letter | 2012 |
Unsedated colonoscopy: an option for some but not for all
|
GASTROINTESTINAL ENDOSCOPY |
Ponencia | 2012 |
Utility of agora criteria in the decision to re-treat patients with Hepatitis C and failure of previous treatment with peg-ifn and RBV
|
HEPATOLOGY |
Ponencia | 2012 |
Validation of FibroMax and NAFLDscore in a cohort of NAFLD Spanish patients
|
HEPATOLOGY |
Ponencia | 2012 |
Vitamin D supplementation influences sustained virological response rate in Hepatitis C: a systematic review and meta-analysis
|
HEPATOLOGY |
Editorial | 2011 |
APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising others
|
JOURNAL OF HEPATOLOGY |
Artículo | 2011 |
Brain biomolecules oxidation in portacaval-shunted rats
|
LIVER INTERNATIONAL |
Editorial | 2011 |
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C
|
ANNALS OF HEPATOLOGY |
Artículo | 2011 |
Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy
|
JOURNAL OF CROHNS & COLITIS |
Ponencia | 2011 |
EFFECTS OF CHEMICAL MOIETIES AND POLYMORPHISMS IN THE HUMAN ABC TRANSPORTER ABCB1 (P-GLYCOPROTEIN/MDR1) IN DRUG-INDUCED LIVER INJURY
|
JOURNAL OF HEPATOLOGY |
Artículo | 2011 |
Endoscopic closure of a rectovaginal fistula combining N-2-butyl-cyanoacrylate (Histoacryl) and Resolution clips
|
ENDOSCOPY |
Artículo | 2011 |
Experimental models for hepatic encephalopathy
|
Revista Española de Enfermedades Digestivas |
Revisión | 2011 |
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
|
LIVER INTERNATIONAL |
Ponencia | 2011 |
HCVAC STUDY: ANTIVIRAL ACTIVITY OF TG4040 THERAPEUTIC VACCINE IN GENOTYPE-1 CHRONIC HCV PATIENTS
|
HEPATOLOGY |
Artículo | 2011 |
Hepatitis C virus and statins: Is there a role?
|
Current Hepatitis Reports |
Ponencia | 2011 |
HEPATITIS C VIRUS INFECTION ALTERS LIPID METABOLISM DEPENDING ON THE RS12979860 POLYMORPHISM IN THE IL28B GENE
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2011 |
HOMA1-IR AND HOMA2-IR INDEXES IN IDENTIFYING INSULIN RESISTANCE IN CHRONIC HEPATITIS C
|
HEPATOLOGY |
Ponencia | 2011 |
IBUPROFEN-ASSOCIATED HEPATOTOXICITY: ANALYSIS OF A CASE SERIES INCLUDED IN THE SPANISH DILI REGISTRY
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2011 |
IBUPROFEN, A FREQUENT CAUSE OF HEPATOTOXICITY. ANALYSIS OF A CASE SERIES
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Artículo | 2011 |
Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Editorial | 2011 |
Insulin resistance and sustained virological response in hepatitis C: from bench to bedside
|
LIVER INTERNATIONAL |
Ponencia | 2011 |
INSULIN RESISTANCE PREDICTS SUSTAINED VIROLOGICAL RESPONSE INDEPENDENTLY TO IL28B RS12979860 POLYMORPHISM IN TREATED PATIENTS WITH CHRONIC HEPATITIS C
|
HEPATOLOGY |
Ponencia | 2011 |
INSULIN SENSITIZER USE WAS ASSOCIATED WITH LOWER RATE OF CIRRHOSIS OUTCOMES: HEPATIC ENCEPHALOPATHY AND SPONTANEOUS BACTERIAL PERITONITIS
|
HEPATOLOGY |
Artículo | 2011 |
La respuesta virológica al tratamiento con adefovir dipivoxil predice el desarrollo de resistencias a largo plazo en pacientes con hepatitis crónica B HBeAg negativo previamente no tratados
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2011 |
LONG-TERM FOLLOW-UP IN PATIENTS WITH ACUTE DRUG-INDUCED LIVER INJURY (DILI)
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Artículo | 2011 |
Meta-analysis: insulin resistance and sustained virological response in hepatitis C
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Ponencia | 2011 |
METFORMIN AND RAPAMYCIN INTERACT WITH INSULIN SIGNALLING PATHWAY AND INHIBIT HCV REPLICATION IN VITRO
|
HEPATOLOGY |
Artículo | 2011 |
Monitoring activities and improvement in the use of antibiotics in Spanish hospitals: results of a national survey
|
Enfermedades infecciosas y microbiología clínica |
Ponencia | 2011 |
NONINVASIVE ASSESSMENT OF LIVER FIBROSIS BY FORNS INDEX IS A PREDICTIVE FACTOR OF RESPONSE SIMILAR TO HISTOLOGICAL FIBROSIS IN PATIENTS WITH HEPATITIS C
|
HEPATOLOGY |
Artículo | 2011 |
Obesity and hepatitis C
|
Gastroenterologia y Hepatologia Continuada |
Resumen congreso | 2011 |
Obesity dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
|
HEPATOLOGY |
Ponencia | 2011 |
ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTS
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2011 |
Perfiles metabólicos dependientes de la obesidad asociados a la progresión del hígado graso no alcohólico
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2011 |
Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half
|
CLINICAL MICROBIOLOGY AND INFECTION |
Ponencia | 2011 |
PROTEOMIC ANALYSIS OF HEPATITIS C INFECTION IN AN IN VITRO MODEL REVEALS A POTENTIAL NEW THERAPEUTIC TARGET: TCTP (TRANSCRIPTION CONTROLLED TUMOR PROTEIN)
|
HEPATOLOGY |
Ponencia | 2011 |
RELATIONSHIP BETWEEN CHEMICAL MOIETIES AND HUMAN ABC TRANSPORTER ABCB1 (P-GLYCOPROTEIN/MDR1) POLYMORPHISMS IN DRUG-INDUCED LIVER INJURY (DILI)
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Ponencia | 2011 |
ROLE OF RAPAMYCIN AS MTOR INHIBITOR IN VITRO AND ITS USE IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
|
JOURNAL OF HEPATOLOGY |
Artículo | 2011 |
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
|
GASTROENTEROLOGY |
Artículo | 2011 |
Talidomida, peginterferón alfa-2b y ribavirina en el tratamiento de pacientes no respondedores con hepatitis crónica C genotipo 1: Estudio piloto
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2011 |
THDP-17 inhibits selectively the k-type intestinal glutaminase, but not the type-l in vitro and in vivo
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2011 |
THE INFLUENCE OF AROMATIC SUBSTITUENTS IN THE GLUTATHIONE S-TRANSFERASE M1 AND T1 DETOXIFYING PROCESS AND THE RISK OF DEVELOPING DRUG-INDUCED LIVER INJURY (DILI)
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Ponencia | 2011 |
THE INFLUENCE OF AROMATIC SUSTITUENTS IN THE GLUTATHIONE S-TRANSFERASE M1 AND T1 DETOXIFYING PROCESS AND THE RISK OF DEVELOPING DRUG-INDUCED LIVER INJURY (DILI)
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Revisión | 2011 |
The role of insulin resistance in HIV/hepatitis C virus-coinfected patients
|
CURRENT OPINION IN HIV AND AIDS |
Ponencia | 2011 |
THE ROLE OF THE ABCB1 2677G > T,A POLYMORPHISM IN BILIRUBIN SUBSTRATE SPECIFICITY IN DRUG-INDUCED LIVER INJURY (DILI)
|
HEPATOLOGY |
Revisión | 2011 |
Use of HOMA-IR in hepatitis C
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2010 |
Campylobacter fetus Peritonitis and Bacteremia in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis
|
JOURNAL OF CLINICAL MICROBIOLOGY |
Artículo | 2010 |
Cronkhite-Canada syndrome: a new case report of this enigmatic and infrequent disease
|
Revista Española de Enfermedades Digestivas |
Artículo | 2010 |
Diagnóstico mediante ultrasonografía endoscópica-paaf (USE-PAAF) de metástasis pancreática
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2010 |
Differential protein expression in the cerebellum of portocaval-shunted rats: a dige/ms study
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2010 |
DOUBLE-BLINDED CROSSOVER TRIAL ANALYZING THE USEFULNESS OF RIFAXIMIN IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY (MHE): AN INTERIN ANALYSIS
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2010 |
Efecto del tratamiento con igf-1 en ratas con encefalopatía hepática por derivación portocava
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 2010 |
Gastric inflammatory fibroid polyp
|
Revista Española de Enfermedades Digestivas |
Artículo | 2010 |
Genética y complicaciones de la cirrosis
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2010 |
Genome-wide association and high throughput genotype imputation studies confirm a susceptibility locus to hcv infection on 6p22.1-p21.31
|
JOURNAL OF HEPATOLOGY |
Letter | 2010 |
Giant gastric fibroid inflammatory polyp
|
Revista Española de Enfermedades Digestivas |
Artículo | 2010 |
Hepatitis C y síndrome metabólico
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2010 |
HLA alleles influence the occurrence and outcome of amoxicillin-clavulanate liver injury in Spanish patients
|
TISSUE ANTIGENS |
Ponencia | 2010 |
IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): FOLLOW-UP IN A COHORT OF PATIENTS IDENTIFIED IN 24 TERTIARY CARE CENTRES IN SPAIN
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2010 |
IGF-1 replacement therapy in rats with hepatic encephalopathy induced by portacaval shunt
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2010 |
IL28B GENETIC VARIANTS AND HEPATITIS VIRUS INFECTION BY DIFFERENT VIRAL GENOTYPES
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2010 |
IL28B POLYMORPHISM PREDICTS SUSTAINED VIROLOGICAL RESPONSE IN HEPATITIS C BUT IS NOT ASSOCIATED WITH FIBROSIS OR VIRAL LOAD
|
HEPATOLOGY |
Resumen congreso | 2010 |
IL28B RS12979860 SNP is associated with lipids metabolism, viral genotype and spontaneous viral clearance in hepatitis C
|
HEPATOLOGY |
Ponencia | 2010 |
IMPORTANCE OF HOST GENETIC FACTOR, HLA AND IL28B, AS PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
|
HEPATOLOGY |
Ponencia | 2010 |
INADECUATE COMPENSATION BY GLUTAMINE SYNTHETASE AND INCREASED GLUTAMINASE ACTIVITY CONTRIBUTES TO HYPERAMMONAEMIA IN CIRRHOSIS
|
HEPATOLOGY |
Artículo | 2010 |
Insulin Resistance and Response to Antiviral Therapy in Chronic Hepatitis C: Mechanisms and Management
|
Digestive Diseases |
Artículo | 2010 |
Insulin resistance in chronic hepatitis C
|
Gastroenterologia y Hepatologia Continuada |
Resumen congreso | 2010 |
Insulin signalling can be blocked in huh7.5 cells transfected with jfh1 by ptpb1 over-expression
|
HEPATOLOGY |
Ponencia | 2010 |
Interaction between chemical structures and genetic variability in the hepatocellular transporter bile salt export pump (bsep) as a susceptibility factor to idiosyncratic drug-induced liver injury (dili)
|
HEPATOLOGY |
Artículo | 2010 |
Interleukin-28B Genetic Variants and Hepatitis Virus Infection by Different Viral Genotypes
|
HEPATOLOGY |
Letter | 2010 |
Metformin Improves Sustained Virologic Response in Difficult-to-Cure Hepatitis C: More Questions than Answers Reply
|
HEPATOLOGY |
Artículo | 2010 |
Mitochondrial Superoxide Dismutase and Glutathione Peroxidase in Idiosyncratic Drug-Induced Liver Injury
|
HEPATOLOGY |
Letter | 2010 |
Observed and Calculated Interleukin-28B Genotype Frequencies in Hepatitis C Virus Infection Reply
|
HEPATOLOGY |
Ponencia | 2010 |
Optical analysis of liver magnetic resonance images for the determination of the stage and distribution of fibrosis in non-alcoholic fatty liver disease
|
HEPATOLOGY |
Ponencia | 2010 |
P-21. Un microsatélite en la región promotora del gen GLS predice el riesgo de la encefalopatía hepática. Análisis funcional "in vitro"
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Póster | 2010 |
P-26. Expresión diferencial de proteínas en cerebelo de ratas con derivación porto-cava: un estudio dige/ms
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2010 |
P-33. Utilidad de la rifaximina en el tratamiento de la encefalopatía hepática mínima: Análisis intermedio
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2010 |
P-78. Tratamiento de la resistencia a la insulina con metformina antes de la terapia antiviral con peginterferón y ribavirina en la hepatitis crónica c. estudio piloto
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2010 |
Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Corrección | 2010 |
Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response (vol 105, pg 2164, 2010)
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Revisión | 2010 |
Pharmacotherapy of hepatic encephalopathy in cirrhosis
|
EXPERT OPINION ON PHARMACOTHERAPY |
Artículo | 2010 |
Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection
|
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY |
Ponencia | 2010 |
Relationship between chemical moieties and genetic variability in the canalicular transporter bile salt export pump (bsep) as a susceptibility factor to idiosyncratic drug-induced liver injury (dili)
|
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY |
Ponencia | 2010 |
Relevancia del polimorfismo funcional de la manganeso superóxido dismutasa (SOD2 VAL16ALA ) y de la glutatión peroxidasa 1 (GPX1 PRO200LEU) en pacientes con daño hepático idiosincrásico inducido por medicamentos (DILI)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2010 |
Serum Metabolic Signature of Minimal Hepatic Encephalopathy by H-1-Nuclear Magnetic Resonance
|
JOURNAL OF PROTEOME RESEARCH |
Ponencia | 2010 |
THDP-17 inhibits the glutaminase activity in caco-2 cell cultures
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2010 |
The HLA class i b*1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver damage and outcome in spanish patients
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2010 |
THE MECHANISM BEHIND SYNERGISTIC ACTION OF LORNITHINE AND PHENYLACETATE TO REDUCE AMMONIA IN CIRRHOTIC RATS
|
HEPATOLOGY |
Ponencia | 2010 |
Un índice de fibrosis basado en el fibrotac y forns mejora el diagnóstico no invasivo de la fibrosis hepática significativa en hepatitis C
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2010 |
Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis A Cohort Study
|
Annals of Internal Medicine |
Ponencia | 2010 |
WOULD IT BE DESIRABLE TO MODIFY THE CUT-OFF POINT FOR DEFINITION OF CHRONICITY IN DRUG-INDUCED LIVER INJURY (DILI)?
|
HEPATOLOGY |
Ponencia | 2010 |
Would it be desirable to modify the cutoff point in the definition of chronicity in drug-induced liver injury (DILI)?
|
HEPATOLOGY |
Ponencia | 2009 |
A MICROSATELLITE IN THE PROMOTER REGION OF THE GLS GENE PREDICTS THE RISK OF HEPATIC ENCEPHALOPATHY: FUNCTIONAL ANALYSIS USING LUCIFERASE REPORTER
|
HEPATOLOGY |
Ponencia | 2009 |
Analisis of causes of response failure in naive patients with chronic hepatitis C receiving peginterferon plus rivavirin
|
HEPATOLOGY |
Corrección | 2009 |
Analysis of IL-10, IL-4 and TNF-alpha Polymorphisms in Drug-induced liver injury (DILI) and its outcome (vol 49, pg 107, 2008)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2009 |
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2009 |
EL POLIMORFISMO 1331T>C EN LA BOMBA EXPORTADORA DE SALES BILIARES ES UN FACTOR DE SUSCEPTIBILIDAD AL DAÑO HEPATOCELULAR INDUCIDO POR FÁRMACOS.
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2009 |
Encefalopatía hepática mínima
|
Revista de Gastroenterología de México |
Ponencia | 2009 |
ESTUDIO DE LA GLUTAMINASA DEPENDIENTE DE FOSFATO POR BLUE-NATIVE PAGE: UNA APROXIMACIÓN PROTEÓMICA
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2009 |
FREQUENCY OF-24 C > T POLYMORPHISM IN THE HEPATIC CANALICULAR TRANSPORTER ABCC2 GENE IN SPANISH POPULATION
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Ponencia | 2009 |
GENOTYPE DISTRIBUTION OF THE HEPATIC CANALICULAR TRANSPORTER ABCC2-24C > T POLYMORPHISM IS NOT RELATED TO DRUG-INDUCED IDIOSYNCRATIC LIVER INJURY (DILI). RELEVANCE OF ETHNIC VARIANTS IN EUROPEANS
|
JOURNAL OF HEPATOLOGY |
Corrección | 2009 |
Glutathione S-Transferase M1 and T1 Null Genotypes Increase Susceptibility to Idiosyncratic Drug-Induced Liver Injury (vol 48, pg 588, 2008)
|
HEPATOLOGY |
Artículo | 2009 |
Gut ammonia production and its modulation
|
METABOLIC BRAIN DISEASE |
Revisión | 2009 |
Hepatitis C virus and diabetes: Epidemiological association and pharmacological intervention
|
Hot Topics in Viral Hepatitis |
Ponencia | 2009 |
IMPORTANCE OF HLA-DQB1(star)0301 AS PREDICTIVE FACTOR OF SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS WITH CHRONIC HEPATITISC (CHC), GENOTYPE-1, TREATED WITH PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2009 |
IMPORTANCIA DEL ALELO HLA-DQB1*0301 COMO FACTOR PREDICTIVO DE RESPUESTA VIROLÓGICA MANTENIDA (RVM) EN PACIENTES CON HEPATITIS CRÓNICA C (HCC), GENOTIPO 1, TRATADOS CON INTERFERÓN PEGILADO Y RIBAVIRINA
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Póster | 2009 |
INHIBICIÓN DE LA GLUTAMINASA INTESTINAL
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2009 |
LA DISTRIBUCIÓN GENOTÍPICA DEL POLIMORFISMO -24C>T EN EL TRANSPORTADOR CANALICULAR ABCC2 NO ESTÁ RELACIONADA CON EL DESARROLLO DE TOXICIDAD HEPÁTICA INDUCIDA POR FÁRMACOS (DILI). RELEVANCIA DE SU VARIABILIDAD ÉTNICA EN LA POBLACIÓN EUROPEA.
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Póster | 2009 |
LA RESISTENCIA A LA INSULINA CORRELACIONA CON EL GRADIENDE DE PRESIÓN PORTAL (HVPG) Y PREDICE EL RIESGO DE SANGRADO POR VARICES ESOFÁGICAS EN PACIENTES CIRRÓTICOS
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2009 |
LINGUISTIC AND TRANSCULTURAL VALIDATION OF THE GASTRO-ESOPHAGEAL REFLUX DISEASE QUESTIONNAIRE FOR A SPANISH POPULATION
|
PATIENT REPORTED OUTCOMES |
Ponencia | 2009 |
MANGANESE SUPEROXIDE DISMUTASE FUNCTIONAL POLYMORPHISM (SOD2 V16A) IS A MAJOR DETERMINANT OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Letter | 2009 |
Metformin, Hepatitis C, and Insulin Resistance: Sufficient Evidence? Reply
|
HEPATOLOGY |
Revisión | 2009 |
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines
|
LIVER INTERNATIONAL |
Ponencia | 2009 |
P.06 Una sobrecarga oral de glutamina alterada en pacientes con encefalopatía hepática mínima valorada mediante la medición de la frecuencia de parpadeo (fcp) predice elevado riesgo de encefalopatía y menor supervivencia
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2009 |
Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex
|
HEPATOLOGY |
Ponencia | 2009 |
POSITIONAL CLONING IN GLS GENE: A MICROSATELLITE IN THE PROMOTER REGION PREDICTS THE RISK OF HEPATIC ENCEPHALOPATHY
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2009 |
PREDICTIVE FACTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH COMPLETE EARLY VIROLOGICAL RESPONSE TO THE TREATMENT OF HEPATITIS C
|
HEPATOLOGY |
Ponencia | 2009 |
PREVALENCIA Y FACTORES IMPLICADOS EN LA DETECCIÓN DEL ALCOHOLISMO SUBREPTICIO
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2009 |
RASTREO MUTACIONAL DEL GEN DE LA GLUTAMINASA: UN MICROSATÉLITE EN EL PROMOTOR DEL GEN PREDICE EL RIESGO DE ENCEFALOPATÍA HEPÁTICA
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2009 |
RELEVANCE OF MANGANESE SUPEROXIDE DISMUTASE (SOD2 VAL16ALA) AND GLUTATHIONE PEROXIDASE1 (GPX1 PRO198LEU) FUNCTIONAL POLYMORPHISMS IN PATIENTS WITH IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI)
|
HEPATOLOGY |
Artículo | 2009 |
Results of a survey about specific inflammatory bowel disease units in Andalusia
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2009 |
ROLE OF POLYMORPHIC BILE SALT EXPORT PUMP (BSEP, ABCB11) AND MULTIDRUG-RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2, ABCC2) TRANSPORTERS IN DRUG-INDUCED LIVER INJURY
|
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
Revisión | 2009 |
Steatosis and insulin resistance in hepatitis C: A way out for the virus?
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2009 |
Tema 1: objetivo del tratamiento y valoración de la respuesta
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2009 |
Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis c patients (trital): proof of concept
|
HEPATOLOGY |
Ponencia | 2009 |
The combined use of fibroct and forns index improves the non-invasive diagnosis of significant liver fibrosis in hepatitis C
|
HEPATOLOGY |
Ponencia | 2009 |
Tratamiento de la resistencia a la insulina en la hepatitis c: resultado final del estudio tric-1
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2009 |
Treatment of Insulin Resistance with Metformin in Naive Genotype 1 Chronic Hepatitis C Patients Receiving Peginterferon Alfa-2a Plus Ribavirin
|
HEPATOLOGY |
Artículo | 2008 |
An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event
|
Revista Española de Enfermedades Digestivas |
Artículo | 2008 |
Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome
|
JOURNAL OF HEPATOLOGY |
Corrección | 2008 |
Analysis of the causes, characteristics and consequences of the reexposure to medicine or compound responsible for an episode of hepatotoxicity (vol 100, pg 278, 2008)
|
Revista Española de Enfermedades Digestivas |
Letter | 2008 |
Colitis seudomembranosa de origen poco frecuente
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2008 |
Combined glutathione-s-transferase M1 and T1 genetic polymorphism and susceptibility to develop drug-induced idiosyncratic liver injury (DILI)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2008 |
Consulta de alta resolución de digestivo en Andalucía: qué es y cómo debe funcionar?
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2008 |
EFFECT OF SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON PLUS RIBAVIRIN THERAPY ON LIVER RELATED FREE SURVIVAL IN HCV CIRRHOTIC PATIENTS. FACTORS PREDICTING VIROLOGICAL RESPONSE
|
HEPATOLOGY |
Artículo | 2008 |
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2008 |
Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2008 |
Glutathione s-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
|
HEPATOLOGY |
Ponencia | 2008 |
GLUTATHIONE-S-TRANSFERASE M1 AND T1 NULL GENOTYPES INCREASE SUSCEPTIBILITY TO IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY
|
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY |
Revisión | 2008 |
Hepatitis C: cryoglobulinemia and non-Hodgkin lymphoma
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2008 |
INSULIN RESISTANCE CORRELATES WITH HVPG AND PREDICTS RISK FOR THE DEVELOPMENT OF VARICEAL BLEEDING IN CIRRHOTICS
|
HEPATOLOGY |
Ponencia | 2008 |
INSULIN RESISTANCE CORRELATES WITH HVPG AND PREDICTS RISK FOR THE DEVELOPMENT OF VARICEAL BLEEDING IN CIRRHOTICS
|
HEPATOLOGY |
Ponencia | 2008 |
Insulin resistance predicts risk for the development of variceal bleeding
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2008 |
Interim analysis from TRIC-1 a study of metformin with peginterferon alfa-2a and ribavirin in treatment naive genotype 1 chronic hepatitis C with insulin resistance
|
JOURNAL OF HEPATOLOGY |
Artículo | 2008 |
Mecanismos de resistencia al interferón en la hepatitis C crónica
|
Hepatitis hoy |
Ponencia | 2008 |
METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN THE TREATMENT OF NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WITH INSULIN RESISTANCE (TRIC-1): FINAL RESULTS OF A RANDOMIZED AND DOUBLE-BLINDED TRIAL
|
HEPATOLOGY |
Artículo | 2008 |
Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C
|
HEPATOLOGY |
Revisión | 2008 |
Pathogenesis and natural course of hepatic steatosis and insulin resistance in patients with hepatitis C
|
Current Hepatitis Reports |
Resumen congreso | 2008 |
Peginterferon plus ribavirin and sustained virological response on HCV cirrhosis: Effect on liver-related event free survival and factors predicting response: A retrospective multicenter analysis
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2008 |
POLYMORPHIC BILE SALT EXPORT PUMP TRANSPORTER IS A MAJOR DETERMINANT OF HEPATOCELLULAR DRUG-INDUCED LIVER INJURY
|
HEPATOLOGY |
Libro | 2008 |
Programación didáctica de primero de Primaria
|
Programación didáctica de primero de Primaria |
Artículo | 2008 |
PTPN22 C1858T Polymorphism and the Outcome of Hepatitis C Virus Infection
|
VIRAL IMMUNOLOGY |
Artículo | 2008 |
Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon-ribavirin
|
JOURNAL OF CLINICAL VIROLOGY |
Ponencia | 2008 |
Smoking and hepatitis C: Influence on fibrosis progression and sustained response
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2008 |
The influence of age and gender in the biochemical expression of idiosyncratic liver injury
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2007 |
Assessment of fibrosis distribution in patients with chronic hepatitis C using computerperformed optical analysis of CT of the liver (FibroCT (R))
|
JOURNAL OF HEPATOLOGY |
Editorial | 2007 |
Caustic esophagitis and gastritis
|
Revista Española de Enfermedades Digestivas |
Artículo | 2007 |
CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2007 |
Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2007 |
Colangiopatía autoinmune: criterios diagnósticos actuales
|
Revista Andaluza de Patología Digestiva |
Artículo | 2007 |
Comentario: fumar perjudica seriamente al hígado
|
Revista Andaluza de Patología Digestiva |
Editorial | 2007 |
Critical flicker frequency: It is time to break down barriers surrounding minimal hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Artículo | 2007 |
Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis
|
DIGESTIVE AND LIVER DISEASE |
Ponencia | 2007 |
Genetic, polymorphisms of Il-10, Il-4 and TNF alpha and susceptibility to develop drug-induced idiosyncratic liver injury (DILI)
|
HEPATOLOGY |
Ponencia | 2007 |
Haplotypes TACG and CACG from glutaminase gene protect against hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2007 |
How can we identify HCV genotype 1 patients who may benefit from an extended treatment duration with peginterferon alpha-2a (40kD) plus RBV?
|
JOURNAL OF HEPATOLOGY |
Artículo | 2007 |
Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: A randomized trial
|
JOURNAL OF VIRAL HEPATITIS |
Ponencia | 2007 |
Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirin
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2007 |
INFLUENCIA DE LA RESISTENCIA A LA INSULINA, FIBROSIS, OBESIDAD Y DOSIS DE RIBAVIRINA EN LA DINAMICA VIRAL EN PACIENTES CON HEPATITIS C GENOTIPO 1 TRATADOS CON PEGINTERFERON Y RIBAVIRINA
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2007 |
LOS HAPLOTIPOS TACG Y CACG DEL GEN DE LA GLUTAMINASA PROTEGEN FRENTE A LA ENCEFALOPATÍA HEPÁTICA
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2007 |
MCP-1 promoter and chemokine receptor CCR2 polymorphisms in Spanish patients with chronic hepatitis C
|
TISSUE ANTIGENS |
Editorial | 2007 |
Pneumatic perforation of the cecum during diagnostic sigmoidoscopy
|
ENDOSCOPY |
Artículo | 2007 |
Treatment of chronic hepatitis C genotype 1 with peginterferon-alpha 2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Letter | 2007 |
Tumor de células granulares cecal y enfermedad de crohn
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2007 |
Valoración de la distribución de la fibrosis en pacientes con hepatitis C mediante análisis óptico de imágenes de TAC de hígado (FIBROTC)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2007 |
Valoración incruenta de la fibrosis en la hepatitis C
|
Hepatitis hoy |
Artículo | 2007 |
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy
|
HEPATOLOGY |
Nota | 2007 |
What is the treatment standard of hepatic encephalopathy? Lessons of clinical trials in the treatment of hepatic encephalopathy
|
Gastroenterologia y Hepatologia Continuada |
Capítulo | 2006 |
1.4. Neuroimagen
|
Tratado SET de Trastornos Adictivos |
Artículo | 2006 |
Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patients
|
JOURNAL OF HEPATOLOGY |
Artículo | 2006 |
Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: Is there still a role for these drugs?
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Ponencia | 2006 |
Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identified
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2006 |
Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI)
|
JOURNAL OF HEPATOLOGY |
Otros | 2006 |
Critical evaluation of estimation methods of fibrosis in chronic hepatitis C
|
Gastroenterologia y Hepatologia Continuada |
Artículo | 2006 |
Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: A prospective series from Spain
|
HEPATOLOGY |
Artículo | 2006 |
Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C
|
HEPATOLOGY |
Letter | 2006 |
Different approaches to therapy of esophageal granular cell tumor (Abrikossoff tumor)
|
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
Ponencia | 2006 |
Effect of sustained response in the incidence of type 2 diabetes mellitus in chronic hepatitis C
|
HEPATOLOGY |
Artículo | 2006 |
Hepatitis C and insulin resistance: steatosis, fibrosis and non-response
|
Revista Española de Enfermedades Digestivas |
Revisión | 2006 |
Hepatitis C and insulin resistance: Steatosis, fibrosis and nonresponse
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2006 |
HLA-C and KIR genes in hepatitis C virus infection
|
TISSUE ANTIGENS |
Artículo | 2006 |
Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
Artículo | 2006 |
Insulin resistance and hepatitis C
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2006 |
Insulin resistance as a non-invasive method for the assessment of fibrosis in patients with hepatitis C: a comparative study of biochemical methods
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2006 |
Insulin resistance in co-infected HCV/HIV patients: A negative factor influencing sustained response to peginterferon plus ribavirin
|
JOURNAL OF HEPATOLOGY |
Artículo | 2006 |
Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure
|
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY |
Otros | 2006 |
Liver diseases in preliminary pregnancy
|
Gastroenterologia y Hepatologia Continuada |
Artículo | 2006 |
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
|
HEPATOLOGY |
Ponencia | 2006 |
Peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) for treating chronic hepatitis C genotype 1 in daily clinical practice: Final results of the Heracles project
|
JOURNAL OF HEPATOLOGY |
Artículo | 2006 |
Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment
|
GASTROENTEROLOGY |
Corrección | 2006 |
Peginterferon-Alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment (vol 131, pg 451, 2006)
|
GASTROENTEROLOGY |
Ponencia | 2006 |
Pharmacokinetics and pharmacodynamics of induction doses of peginterferon alpha-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in HCV genotype 1 patients who failed to respond to interferon/ribavirin
|
JOURNAL OF HEPATOLOGY |
Artículo | 2006 |
Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Ponencia | 2006 |
Phosphate-activated glutaminase gene polymorphisms are implied in cirrhosis susceptibility and risk for hepatic encephalopathy
|
HEPATOLOGY |
Ponencia | 2006 |
Protein oxidation in astrocyte of porto-caval shunted rats: Role of oxidative stress in hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Artículo | 2006 |
Results of a survey in Andalusian Endoscopy Units
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2006 |
Sustained response in chronic hepatitis C reduces the risk to develop impaired fasting glucose and/or diabetes mellitus type 2
|
JOURNAL OF HEPATOLOGY |
Artículo | 2006 |
Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima
|
MEDICINA CLINICA |
Artículo | 2006 |
Tratamiento de la hepatitis crónica C por genotipos 2 y 3: revisión sistemática
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2006 |
Treatment of chronic hepatitis c genotype 1 with peginterferona2a (40 kda) plus ribavirin under routine clinical practice in spain: early prediction of sustained virological response rate
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Ponencia | 2006 |
Usefulness of the measurement of critical flicker frequency in the diagnosis of minimal hepatic encephalopathy (MHE)
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2005 |
Are there differences in sustained virological response (SVR)rates in patients with HCV genotype 2 or 3 infection and persistently 'normal' ALT activity undergoing treatment with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R))?
|
HEPATOLOGY |
Ponencia | 2005 |
Bcl-2 expression in ductular proloferation induces fibrosis progression promoting activation of hepatic stellate cells in autoimmune cholestasis
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2005 |
Development and validation of a simple model to predict response to peginterferon plus ribavirin combination therapy in genotype 1 chronic hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2005 |
DRUG-INDUCED LIVER INJURY: AN ANALYSIS OF 461 INCIDENCES SUBMITTED TO THE SPANISH REGISTRY OVER A 10-YEAR PERIOD
|
GASTROENTEROLOGY |
Corrección | 2005 |
Erratum: Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period (Gastroenterology (2005) 129 (512-521))
|
GASTROENTEROLOGY |
Artículo | 2005 |
Estudio comparativo de dos modelos que utilizan parámetros bioquímicos en el diagnóstico no invasivo de la fibrosis hepática en pacientes con hepatitis C
|
MEDICINA CLINICA |
Ponencia | 2005 |
Fibrosis assessment in hepatitis C by computerper-formed optical analysis of CT of the liver: A novel nowinvasive and useful method
|
JOURNAL OF HEPATOLOGY |
Artículo | 2005 |
GLUTAMINASA INTESTINAL Y ENCEFALOPATÍA HEPÁTICA.
|
Gastroenterologia y Hepatologia Continuada |
Ponencia | 2005 |
Glutaminase activity is implicated in the pathogenesis of hyperammonemia in portocaval shunted rats
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2005 |
Hepatic encephalopathy is more frequent, severe and shortens the survival in HCV/HIV-related cirrhosis
|
JOURNAL OF HEPATOLOGY |
Editorial | 2005 |
HEPATITIS C: ARE THERE ANY OPTIONS FOR NON-RESPONDERS?
|
Revista Española de Enfermedades Digestivas |
Letter | 2005 |
HEPATOTOXICIDAD INDUCIDA POR PAROXETINA
|
MEDICINA CLINICA |
Artículo | 2005 |
HIV coinfection shortens the survival of patients with hepatitis c virus-related decompensated cirrhosis
|
HEPATOLOGY |
Artículo | 2005 |
HLA-C and KIR genes in hepatitis C virus infection
|
Human Immunology |
Ponencia | 2005 |
INCIDENCIA DE HEPATOCARCINOMA EN PACIENTES INFECTADOS POR VHC CON CIRROSIS HEPÁTICA DESCOMPENSADA, INFECTADOS O NO POR VIH
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2005 |
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
|
GASTROENTEROLOGY |
Ponencia | 2005 |
Insulin resistance promotes fibrosis progression and predicts necro-inflammatory activity in patients with non-alcoholic fatty liver disease
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2005 |
Oral glutamine challenge response is regulated by portal hypertension and systemic inflammatory response
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2005 |
Preliminary health outcome results of peginterferon alpha-2a (40kDa) plus ribavirin treatment for chronic hepatitis C genotype 1 in daily routine clinical practice: The heracles project
|
JOURNAL OF HEPATOLOGY |
Artículo | 2005 |
Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy
|
METABOLIC BRAIN DISEASE |
Ponencia | 2004 |
ASOCIACION ENTRE HLA-B44 Y RESPUESTA SOSTENIDA AL TRATAMIENTO INTERFERON + RIBAVIRINA EN PACIENTES CON HEPATITIS CRONICA POR VIRUS C
|
Inmunología |
Libro | 2004 |
Carcinoma hepatocelular
|
Carcinoma hepatocelular |
Artículo | 2004 |
Determinación del genotipo del virus de la hepatitis B y detección de mutaciones de resistencia al tratamiento con lamivudina
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Revisión | 2004 |
ENCEFALOPATÍA HEPÁTICA. CLASIFICACIÓN Y MANIFESTACIONES CLÍNICAS
|
Gastroenterologia y Hepatologia Continuada |
Corrección | 2004 |
Erratum: Tumor estromal de localización gástrica (Gastroenterologia y Hepatologia (2004) 27, 7 (429-435))
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2004 |
EVALUACIÓN DIAGNÓSTICA Y AVANCES TERAPÉUTICOS EN LA ENCEFALOPATÍA HEPÁTICA
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2004 |
EXPRESION DE LA GLUTAMINASA FOSFATO DEPENDIENTE INTESTINAL EN LA ENCEFALOPATÍA HEPATICA MINIMA
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2004 |
FACTORES REGULADORES DE LA PRODUCCION INTESTINAL DE AMONIO
|
Revista Española de Enfermedades Digestivas |
Letter | 2004 |
Hepatotoxicity induced by clopidogrel
|
JOURNAL OF HEPATOLOGY |
Artículo | 2004 |
Histologic features of steatohepatitis in patients with a clinical diagnosis of autoirnmune cholestasis
|
DIGESTIVE DISEASES AND SCIENCES |
Ponencia | 2004 |
HLA class IB44 is associated with sustained response to interferon plus ribavirin therapy in patients with chronic hepatitis C
|
Genes & Immunity |
Artículo | 2004 |
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
|
HEPATOLOGY |
Ponencia | 2004 |
Increased phosphate-activated glutaminase activity contributes substantially to the hyperammonemia in acute liver failure.
|
HEPATOLOGY |
Ponencia | 2004 |
Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2004 |
Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Ponencia | 2004 |
Longer treatment duration with peginterferon alfa-2A (40kd) (Pegasys (R)) and ribavirin (Copegus (R)) in naive patients with chronic hepatitis C and detectable HCV RNA by week 4 of therapy: Final results of the randomized, multicenter TeraViC-4 study
|
HEPATOLOGY |
Revisión | 2004 |
Nuevos conceptos en la fisiopatología de la encefalopatía hepática y perspectivas terapéuticas
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2004 |
Peginterferon alfa-2a (40KD) (Pegasys (R)) and ribavirin (Copegus (R)) in patients infected with HCV genotype 1 who failed to respond to interferon and ribavirin: Final results of the Spanish High-Dose Induction Pilot Trial.
|
HEPATOLOGY |
Letter | 2004 |
Peritonitis bacteriana espontánea por Streptococcus anginosus
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2004 |
Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy
|
HEPATOLOGY |
Ponencia | 2004 |
RELACIÓN ENTRE LA INFECCION CRÓNICA POR VIRUS C Y LOS GENES MCP-1 Y CCR2
|
Inmunología |
Artículo | 2004 |
Serum immunological profile in patients with chronic autoimmune cholestasis
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2004 |
SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C
|
GUT |
Ponencia | 2004 |
Sustained virological response after prolonged treatment with peginterferon alfa-2a (40kd) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in treatment-naive patients with chronic hepatitis C and detectable HCV RNA after week 4 of therapy: Teravic-4 study
|
JOURNAL OF HEPATOLOGY |
Letter | 2004 |
Transient Budd-Chiari syndrome due to iatrogenic subcapsular fluid accumulation following thoracocentesis
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2004 |
Tumor carcinoide ileal y colitis autolimitada
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 2004 |
Tumor estromal de localización gástrica
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2004 |
Tumour necrosis factor alpha polymorphisms are not involved in the development of steatosis in chronic hepatitis C
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Resumen congreso | 2004 |
Usefulness of "Interpolated visualization" in brain Mri of cirrhotic patients as a diagnostic tool of minimal hepatic encephalopathy
|
European Radiology |
Letter | 2003 |
Bursitis bacteriana espontánea en un paciente con cirrosis hepática
|
MEDICINA CLINICA |
Artículo | 2003 |
COMPARATIVE STUDY OF THE EFFICACY OF AN INDUCTION DOSE OF INTERFERON-ALFA 2B WITH RIBAVIRIN COMPARED WITH STANDARD COMBINED TREATMENT IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C
|
JOURNAL OF VIRAL HEPATITIS |
Ponencia | 2003 |
Computer-performed optical analysis of conventional helical CT of the liver could predict liver fibrosis staging in patients with chronic hepatitis C.
|
HEPATOLOGY |
Artículo | 2003 |
ETIOPATOGENIA Y DIAGNÓSTICO DE LA CIRROSIS BILIAR PRIMARIA
|
Gastroenterologia y Hepatologia Continuada |
Artículo | 2003 |
Familial mediterranean fever and sterility. Case report
|
Revista Iberoamericana de Fertilidad y Reproducción Humana |
Letter | 2003 |
Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Letter | 2003 |
Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome [6]
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Letter | 2003 |
Fatigue is associated with high circulating leptin levels in chronic hepatitis C
|
GUT |
Letter | 2003 |
HEPATITIS AGUDA POR MONTELUKAST
|
MEDICINA CLINICA |
Ponencia | 2003 |
High-dose peginterferon alfa-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in patients infected with hepatitis C virus (HCV) genotype 1 who failed to respond to interferon alfa and ribavirin.
|
HEPATOLOGY |
Ponencia | 2003 |
HLA CLASS I B44 IS ASSOCIATED WITH SUSTAINED RESPONSE TO INTERFERON + RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2003 |
HLA class IB44 is associated with sustained response to interferon plus ribavirin therapy in patients with chronic hepatitis C
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2003 |
Insulin resistance impairs sustained response rate to antiviral therapy in patients with chronic hepatitis C.
|
HEPATOLOGY |
Ponencia | 2003 |
Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy
|
JOURNAL OF HEPATOLOGY |
Letter | 2003 |
Lansoprazole-induced hepatic dysfunction
|
ANNALS OF PHARMACOTHERAPY |
Ponencia | 2003 |
Longer treatment duration with peginterferon alfa-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in naive patients with chronic hepatitis C and detectable HCV RNA by week 4 of therapy: Preliminary results of the TeraVIC-4 study.
|
HEPATOLOGY |
Letter | 2003 |
Macro-AST as cause of unknown hypertransaminasaemia
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Artículo | 2003 |
Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2003 |
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Letter | 2003 |
Tratamiento de la colitis ulcerosa corticorrefractaria con inflisimab
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2002 |
Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Letter | 2002 |
Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding
|
GASTROENTEROLOGY |
Letter | 2002 |
Colestasis gravídica con elevación de las transaminasas sugestiva de hepatitis aguda
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2002 |
FACTORES AGRAVANTES DE LA LESIÓN HEPÁTICA EN LA HEPATITIS CRÓNICA C
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2002 |
HLA AND TNF POLYMORPHISMS IN SPANISH PATIENTS WITH CHRONIC HEPATITIS C
|
EUROPEAN JOURNAL OF IMMUNOGENETICS |
Letter | 2002 |
Infliximab induces remission of pyoderma gangrenosum
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Ponencia | 2002 |
Oral glutamine challenge correlates with minimal hepatic encephalopathy and predicts overt episodes
|
JOURNAL OF HEPATOLOGY |
Artículo | 2002 |
Rationale and design of TeraViC-4 study: A phase III, randomized clinical trial to evaluate the effects of treatment duration with peginterferon alfa-2a (40-kDa) and ribavirin in naive patients with chronic hepatitis C virus infection without early virological response at week 4
|
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY |
Ponencia | 2002 |
Role of leptin and hepatic stellate cell (HSC) in the development of steatosis in chronic hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2002 |
The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer
|
Revista Española de Enfermedades Digestivas |
Artículo | 2002 |
TRATAMIENTO MEDICO DE LA PANCREATITIS CRÓNICA
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2002 |
VIRAL DINAMIC HEPATITIS C IN PATIENTS TREATED WITH PEGILATED INTERFERON PLUS RIBAVIRIN
|
CLINICAL MICROBIOLOGY AND INFECTION |
Artículo | 2001 |
Flutamide-induced hepatotoxicity: report of a case series
|
Revista Española de Enfermedades Digestivas |
Letter | 2001 |
Hepatotoxicity induced by fosinopril
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2001 |
Host and viral factors in hepatocyte steatosis detected in chronic hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2001 |
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption
|
DIGESTIVE AND LIVER DISEASE |
Artículo | 2001 |
Lesiones del tracto digestivo superior causadas por la ingestión de cáusticos
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Ponencia | 2001 |
Oral glutamine challenge in patients with subclinical hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2001 |
Pathogenesis of hyperintensity in the globus palidus (HIGP) in cirrhotic patients
|
JOURNAL OF HEPATOLOGY |
Artículo | 2001 |
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Ponencia | 2001 |
Tratamiento actual de la hepatitis B
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 2000 |
Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease
|
HEPATOLOGY |
Revisión | 2000 |
Acute pancreatitis complicated by a tubercular abscess
|
ANALES DE MEDICINA INTERNA |
Artículo | 2000 |
Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis
|
JOURNAL OF CLINICAL GASTROENTEROLOGY |
Letter | 2000 |
Carcinoma anal en la enfermedad de Crohn
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2000 |
Cartas al Editor
|
MEDICINA CLINICA |
Artículo | 2000 |
COLITIS ISQUÉMICA POR SUMATRIPTAN Y DIHIDROERGOTAMINA
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2000 |
HLA antigens in chronic hepatitis C: Relationship with interferon response and severity of liver injury
|
JOURNAL OF HEPATOLOGY |
Artículo | 2000 |
Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection
|
Revista Española de Enfermedades Digestivas |
Revisión | 2000 |
LINFOMAS DEL TUBO DIGESTIVO. CLASIFICACIÓN Y ASPECTOS HISTOPATOLÓGICOS
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2000 |
Manganese level in patients with subclinical hepatic encephalopathy (SHE)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2000 |
Multicenter retrospective study of response to interferon in chronic hepatitis B
|
Revista Española de Enfermedades Digestivas |
Letter | 2000 |
PAPEL ETIOPATOGÉNICO DEL VIRUS DE LA HEPATITIS C EN EL SÍNDROME ANTIFOSFOLIPÍDICO. CONTESTACIÓN
|
MEDICINA CLINICA |
Artículo | 2000 |
Prevalence and clinical significance of antibiotic resistance in Helicobacter pylori
|
Revista Española de Enfermedades Digestivas |
Ponencia | 2000 |
PREVALENCE AND CLINICAL SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES (APA) IN VIRAL CHRONIC LIVER DISEASE
|
JOURNAL OF HEPATOLOGY |
Artículo | 2000 |
Prevalence and clinical significance of antiphospholipid antibodies in chronic hepatitis C
|
MEDICINA CLINICA |
Artículo | 2000 |
Usefulness of Helicobacter pylori antigens detection in stools for infection diagnosis and confirming eradication
|
MEDICINA CLINICA |
Letter | 1999 |
Acute cholestatic hepatitis induced by nimesulide [1]
|
Liver |
Letter | 1999 |
Acute hepatitis during ritodrine therapy [1]
|
MEDICINA CLINICA |
Letter | 1999 |
Acute hepatitis related to omeprazole
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Letter | 1999 |
Acute hepatitis related to omeprazole [15]
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 1999 |
Acute liver injury associated with the use of ebrotidine, a new H2- receptor antagonist
|
JOURNAL OF HEPATOLOGY |
Letter | 1999 |
Acute pancreatitis and retroperitoneal fibrosis
|
Revista Española de Enfermedades Digestivas |
Revisión | 1999 |
Anti-Sp100 y anti-Gp210 en el diagnóstico de cirrosis biliar primaria en pacientes con colangitis autoinmune
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 1999 |
FIBROSIS RETROPERITONEAL Y PANCREATITIS
|
Revista Española de Enfermedades Digestivas |
Letter | 1999 |
HEPATITIS AGUDA POR NIMESULIDA: DESCRIPCIÓN DE TRES CASOS
|
MEDICINA CLINICA |
Artículo | 1999 |
Hepatitis aguda por ritodrina
|
MEDICINA CLINICA |
Ponencia | 1999 |
HLA class-II antigens in chronic hepatitis C: Relationship with interferon response and severity of liver disease.
|
HEPATOLOGY |
Letter | 1999 |
Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Letter | 1999 |
Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis [10]
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Letter | 1999 |
Pancreatic abscess due to Streptococcus salivarius after dental manipulation
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 1999 |
Trombosis portal como primera manifestación trombótica del sindrome antifosfolípido primario
|
Revista Española de Enfermedades Digestivas |
Artículo | 1999 |
Ulcera ileal y estenosis colónica tipo diafragma por diclofenaco
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 1999 |
UTILIDAD DE LA VITAMINA K EN CIRROSIS HEPÁTICA
|
ATENCION PRIMARIA |
Letter | 1998 |
Budd-Chiari syndrome and primary myelofibrosis
|
SANGRE |
Letter | 1998 |
Carcinoma epidermoide de esofago sobre estenosis caustica esofagica
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 1998 |
Estudio prospectivo sobre la influencia de la hemorragia por ulcus gastroduodenal en los métodos diagnósticos de infección por helicobacter pylori
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 1998 |
Influencia del embarazo en la infección crónica por el virus C de la hepatitis
|
MEDICINA CLINICA |
Ponencia | 1998 |
Is subclinical hepatic encephalopathy a condition for further episodes of overt hepatic encephalopathy?
|
HEPATOLOGY |
Ponencia | 1998 |
Long-term follow-up of patients with chronic hepatitis C and sustained response to interferon therapy.
|
HEPATOLOGY |
Letter | 1998 |
Pseudomembranous colitis induced by diclofenac
|
JOURNAL OF CLINICAL GASTROENTEROLOGY |
Artículo | 1998 |
Sarcoidosis, sclerosing cholangitis, and chronic atrophic autoimmune gastritis - A case of infiltrative sclerosing cholangitis
|
JOURNAL OF CLINICAL GASTROENTEROLOGY |
Artículo | 1997 |
Características clínicas de la enfermedad de Gaucher tipo I en España. Resultados preliminares de una encuesta nacional
|
MEDICINA CLINICA |
Letter | 1997 |
Un caso de hepatitis aguda E en Sevilla
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 1996 |
Retrospective multicentric study on the efficacy of alpha interferon in chronic hepatitis C
|
MEDICINA CLINICA |
Artículo | 1987 |
Malignant and atypical meningiomas: A reappraisal of clinical, histological, and computed tomographic features
|
Neurosurgery |